• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 10-Q filed by Reliance Global Group Inc.

    7/25/24 4:10:47 PM ET
    $RELI
    Specialty Insurers
    Finance
    Get the next $RELI alert in real time by email
    false Q2 --12-31 0001812727 0001812727 2024-01-01 2024-06-30 0001812727 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001812727 RELI:SeriesWarrantsMember 2024-01-01 2024-06-30 0001812727 2024-07-25 0001812727 2024-06-30 0001812727 2023-12-31 0001812727 us-gaap:NonrelatedPartyMember 2024-06-30 0001812727 us-gaap:NonrelatedPartyMember 2023-12-31 0001812727 us-gaap:RelatedPartyMember 2024-06-30 0001812727 us-gaap:RelatedPartyMember 2023-12-31 0001812727 2024-04-01 2024-06-30 0001812727 2023-04-01 2023-06-30 0001812727 2023-01-01 2023-06-30 0001812727 us-gaap:NonrelatedPartyMember 2024-04-01 2024-06-30 0001812727 us-gaap:NonrelatedPartyMember 2023-04-01 2023-06-30 0001812727 us-gaap:NonrelatedPartyMember 2024-01-01 2024-06-30 0001812727 us-gaap:NonrelatedPartyMember 2023-01-01 2023-06-30 0001812727 us-gaap:RelatedPartyMember 2024-04-01 2024-06-30 0001812727 us-gaap:RelatedPartyMember 2023-04-01 2023-06-30 0001812727 us-gaap:RelatedPartyMember 2024-01-01 2024-06-30 0001812727 us-gaap:RelatedPartyMember 2023-01-01 2023-06-30 0001812727 us-gaap:CommonStockMember 2023-12-31 0001812727 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001812727 us-gaap:RetainedEarningsMember 2023-12-31 0001812727 us-gaap:CommonStockMember 2024-03-31 0001812727 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001812727 us-gaap:RetainedEarningsMember 2024-03-31 0001812727 2024-03-31 0001812727 us-gaap:CommonStockMember 2022-12-31 0001812727 us-gaap:AdditionalPaidInCapitalMember 2022-12-31 0001812727 us-gaap:RetainedEarningsMember 2022-12-31 0001812727 2022-12-31 0001812727 us-gaap:CommonStockMember 2023-03-31 0001812727 us-gaap:AdditionalPaidInCapitalMember 2023-03-31 0001812727 us-gaap:RetainedEarningsMember 2023-03-31 0001812727 2023-03-31 0001812727 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001812727 us-gaap:AdditionalPaidInCapitalMember 2024-01-01 2024-03-31 0001812727 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001812727 2024-01-01 2024-03-31 0001812727 us-gaap:CommonStockMember 2024-04-01 2024-06-30 0001812727 us-gaap:AdditionalPaidInCapitalMember 2024-04-01 2024-06-30 0001812727 us-gaap:RetainedEarningsMember 2024-04-01 2024-06-30 0001812727 us-gaap:CommonStockMember 2023-01-01 2023-03-31 0001812727 us-gaap:AdditionalPaidInCapitalMember 2023-01-01 2023-03-31 0001812727 us-gaap:RetainedEarningsMember 2023-01-01 2023-03-31 0001812727 2023-01-01 2023-03-31 0001812727 us-gaap:CommonStockMember 2023-04-01 2023-06-30 0001812727 us-gaap:AdditionalPaidInCapitalMember 2023-04-01 2023-06-30 0001812727 us-gaap:RetainedEarningsMember 2023-04-01 2023-06-30 0001812727 us-gaap:CommonStockMember 2024-06-30 0001812727 us-gaap:AdditionalPaidInCapitalMember 2024-06-30 0001812727 us-gaap:RetainedEarningsMember 2024-06-30 0001812727 us-gaap:CommonStockMember 2023-06-30 0001812727 us-gaap:AdditionalPaidInCapitalMember 2023-06-30 0001812727 us-gaap:RetainedEarningsMember 2023-06-30 0001812727 2023-06-30 0001812727 us-gaap:MeasurementInputSharePriceMember 2024-06-30 0001812727 us-gaap:MeasurementInputSharePriceMember 2023-12-31 0001812727 us-gaap:MeasurementInputPriceVolatilityMember 2024-06-30 0001812727 us-gaap:MeasurementInputPriceVolatilityMember 2023-12-31 0001812727 us-gaap:MeasurementInputExpectedTermMember 2024-06-30 0001812727 us-gaap:MeasurementInputExpectedTermMember 2023-12-31 0001812727 us-gaap:MeasurementInputExpectedDividendRateMember 2024-06-30 0001812727 us-gaap:MeasurementInputExpectedDividendRateMember 2023-12-31 0001812727 us-gaap:MeasurementInputRiskFreeInterestRateMember 2024-06-30 0001812727 us-gaap:MeasurementInputRiskFreeInterestRateMember 2023-12-31 0001812727 RELI:SeriesBWarrantLiabilitiesMember 2023-12-31 0001812727 RELI:PlacementAgentWarrantsMember 2023-12-31 0001812727 RELI:SeriesBWarrantLiabilitiesMember 2024-01-01 2024-03-31 0001812727 RELI:PlacementAgentWarrantsMember 2024-01-01 2024-03-31 0001812727 RELI:SeriesBWarrantLiabilitiesMember 2024-03-31 0001812727 RELI:PlacementAgentWarrantsMember 2024-03-31 0001812727 RELI:SeriesBWarrantLiabilitiesMember 2024-04-01 2024-06-30 0001812727 RELI:PlacementAgentWarrantsMember 2024-04-01 2024-06-30 0001812727 RELI:SeriesBWarrantLiabilitiesMember 2024-06-30 0001812727 RELI:PlacementAgentWarrantsMember 2024-06-30 0001812727 us-gaap:FairValueInputsLevel3Member 2023-01-01 2023-12-31 0001812727 2023-01-01 2023-12-31 0001812727 RELI:MedicalMember RELI:RegularMember 2024-04-01 2024-06-30 0001812727 RELI:LifeMember RELI:RegularMember 2024-04-01 2024-06-30 0001812727 RELI:PropertyAndCasualtyMember RELI:RegularMember 2024-04-01 2024-06-30 0001812727 RELI:MedicalMember RELI:RegularMember 2023-04-01 2023-06-30 0001812727 RELI:LifeMember RELI:RegularMember 2023-04-01 2023-06-30 0001812727 RELI:PropertyAndCasualtyMember RELI:RegularMember 2023-04-01 2023-06-30 0001812727 RELI:MedicalMember RELI:RegularMember 2024-01-01 2024-06-30 0001812727 RELI:LifeMember RELI:RegularMember 2024-01-01 2024-06-30 0001812727 RELI:PropertyAndCasualtyMember RELI:RegularMember 2024-01-01 2024-06-30 0001812727 RELI:MedicalMember RELI:RegularMember 2023-01-01 2023-06-30 0001812727 RELI:LifeMember RELI:RegularMember 2023-01-01 2023-06-30 0001812727 RELI:PropertyAndCasualtyMember RELI:RegularMember 2023-01-01 2023-06-30 0001812727 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember RELI:PriorityHealthMember 2024-04-01 2024-06-30 0001812727 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember RELI:PriorityHealthMember 2023-04-01 2023-06-30 0001812727 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember RELI:BlueCrossBlueShieldMember 2024-04-01 2024-06-30 0001812727 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember RELI:BlueCrossBlueShieldMember 2023-04-01 2023-06-30 0001812727 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember RELI:PriorityHealthMember 2024-01-01 2024-06-30 0001812727 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember RELI:PriorityHealthMember 2023-01-01 2023-06-30 0001812727 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember RELI:BlueCrossBlueShieldMember 2024-01-01 2024-06-30 0001812727 us-gaap:CustomerConcentrationRiskMember us-gaap:SalesRevenueNetMember RELI:BlueCrossBlueShieldMember 2023-01-01 2023-06-30 0001812727 us-gaap:CustomerRelationshipsMember us-gaap:SegmentDiscontinuedOperationsMember 2024-06-30 0001812727 us-gaap:DevelopedTechnologyRightsMember us-gaap:SegmentDiscontinuedOperationsMember 2024-06-30 0001812727 RELI:PurchasedSoftwareMember us-gaap:SegmentDiscontinuedOperationsMember 2024-06-30 0001812727 us-gaap:TrademarksAndTradeNamesMember 2024-06-30 0001812727 RELI:InternallyDevelopedSoftwareMember 2024-06-30 0001812727 us-gaap:CustomerRelationshipsMember 2024-06-30 0001812727 RELI:PurchasedSoftwareMember 2024-06-30 0001812727 RELI:VideoProductionAssetsMember 2024-06-30 0001812727 RELI:NoncompetitionAgreementsMember 2024-06-30 0001812727 us-gaap:TrademarksAndTradeNamesMember 2023-12-31 0001812727 RELI:InternallyDevelopedSoftwareMember 2023-12-31 0001812727 us-gaap:CustomerRelationshipsMember 2023-12-31 0001812727 RELI:PurchasedSoftwareMember 2023-12-31 0001812727 RELI:VideoProductionAssetsMember 2023-12-31 0001812727 RELI:NoncompetitionAgreementsMember 2023-12-31 0001812727 RELI:EBSandUSBAMember 2024-06-30 0001812727 RELI:EBSandUSBAMember 2023-12-31 0001812727 RELI:CCSMember 2024-06-30 0001812727 RELI:CCSMember 2023-12-31 0001812727 RELI:SWMTMember 2024-06-30 0001812727 RELI:SWMTMember 2023-12-31 0001812727 RELI:FISMember 2024-06-30 0001812727 RELI:FISMember 2023-12-31 0001812727 RELI:ABCMember 2024-06-30 0001812727 RELI:ABCMember 2023-12-31 0001812727 RELI:BarraMember 2024-06-30 0001812727 RELI:BarraMember 2023-12-31 0001812727 RELI:EBSandUSBAMember 2024-01-01 2024-06-30 0001812727 RELI:CCSMember 2024-01-01 2024-06-30 0001812727 RELI:SWMTMember 2024-01-01 2024-06-30 0001812727 RELI:FISMember 2024-01-01 2024-06-30 0001812727 RELI:ABCMember 2024-01-01 2024-06-30 0001812727 RELI:BarraMember 2024-01-01 2024-06-30 0001812727 RELI:SeriesBWarrantMember 2024-06-18 0001812727 us-gaap:CommonStockMember 2024-06-18 0001812727 RELI:SeriesBWarrantMember 2024-04-01 2024-06-30 0001812727 RELI:SeriesBWarrantMember 2024-01-01 2024-06-30 0001812727 RELI:SeriesBWarrantMember 2023-04-01 2023-06-30 0001812727 RELI:SeriesBWarrantMember 2023-01-01 2023-06-30 0001812727 RELI:SeriesBWarrantLiabilityMember 2024-06-30 0001812727 RELI:PAWMember 2024-06-30 0001812727 RELI:SeriesBWarrantLiabilityMember 2024-01-01 2024-06-30 0001812727 RELI:PAWMember 2024-01-01 2024-06-30 0001812727 RELI:SeriesBWarrantLiabilityMember 2023-06-30 0001812727 RELI:PAWMember 2023-06-30 0001812727 RELI:SeriesBWarrantLiabilityMember 2023-01-01 2023-06-30 0001812727 RELI:PAWMember 2023-01-01 2023-06-30 0001812727 2024-06-28 2024-06-28 0001812727 RELI:BoardOfDirectorsMember 2024-06-28 2024-06-28 0001812727 us-gaap:CommonStockMember 2024-01-01 2024-06-30 0001812727 RELI:SeriesGWarrantsMember 2024-04-01 2024-06-30 0001812727 us-gaap:CommonStockMember us-gaap:InvestorMember 2024-01-01 2024-03-31 0001812727 us-gaap:CommonStockMember us-gaap:InvestorMember 2024-04-01 2024-06-30 0001812727 RELI:SeriesGWarrantsMember srt:MaximumMember 2024-06-30 0001812727 RELI:SeriesGWarrantsMember srt:MinimumMember 2024-06-30 0001812727 RELI:SeriesGWarrantsMember 2024-06-18 0001812727 us-gaap:CommonStockMember RELI:SeriesGWarrantsMember 2024-06-18 0001812727 RELI:SeriesGWarrantsMember 2024-06-30 0001812727 us-gaap:CommonStockMember RELI:ATMAgreementMember 2024-01-01 2024-06-30 0001812727 RELI:ATMAgreementMember us-gaap:CommonStockMember 2024-06-30 0001812727 us-gaap:CommonStockMember RELI:ATMAgreementMember us-gaap:SubsequentEventMember 2024-07-01 2024-07-31 0001812727 us-gaap:EmployeeStockOptionMember 2024-04-01 2024-06-30 0001812727 us-gaap:EmployeeStockOptionMember 2023-04-01 2023-06-30 0001812727 RELI:SeriesAWarrantsMember 2024-04-01 2024-06-30 0001812727 RELI:SeriesAWarrantsMember 2023-04-01 2023-06-30 0001812727 RELI:PAWMember 2024-04-01 2024-06-30 0001812727 RELI:PAWMember 2023-04-01 2023-06-30 0001812727 RELI:SeriesFWarrantsMember 2024-04-01 2024-06-30 0001812727 RELI:SeriesFWarrantsMember 2023-04-01 2023-06-30 0001812727 RELI:PlacementAgentWarrantsMember 2024-04-01 2024-06-30 0001812727 RELI:PlacementAgentWarrantsMember 2023-04-01 2023-06-30 0001812727 us-gaap:SeriesBPreferredStockMember 2024-04-01 2024-06-30 0001812727 us-gaap:SeriesBPreferredStockMember 2023-04-01 2023-06-30 0001812727 us-gaap:EmployeeStockOptionMember 2024-01-01 2024-06-30 0001812727 us-gaap:EmployeeStockOptionMember 2023-01-01 2023-06-30 0001812727 RELI:SeriesAWarrantsMember 2024-01-01 2024-06-30 0001812727 RELI:SeriesAWarrantsMember 2023-01-01 2023-06-30 0001812727 RELI:PAWMember 2024-01-01 2024-06-30 0001812727 RELI:PAWMember 2023-01-01 2023-06-30 0001812727 RELI:SeriesGWarrantsMember 2024-01-01 2024-06-30 0001812727 RELI:SeriesGWarrantsMember 2023-01-01 2023-06-30 0001812727 RELI:PlacementAgentWarrantsMember 2024-01-01 2024-06-30 0001812727 RELI:PlacementAgentWarrantsMember 2023-01-01 2023-06-30 0001812727 us-gaap:SeriesBPreferredStockMember 2024-01-01 2024-06-30 0001812727 us-gaap:SeriesBPreferredStockMember 2023-01-01 2023-06-30 0001812727 RELI:EmployeeMember RELI:PurchaseAgreementMember 2023-09-29 0001812727 RELI:EmployeeMember RELI:PurchaseAgreementMember 2023-09-29 2023-09-29 0001812727 RELI:EmployeeMember RELI:PurchaseAgreementMember 2024-03-29 0001812727 RELI:EmployeeMember RELI:PurchaseAgreementMember 2024-03-29 2024-03-29 0001812727 RELI:EmployeeMember RELI:PurchaseAgreementMember 2024-04-30 0001812727 RELI:EmployeeMember RELI:PurchaseAgreementMember 2024-04-30 2024-04-30 0001812727 us-gaap:AssetsMember 2024-06-30 0001812727 RELI:StockExchangeAgreementMember RELI:SpetnerAssociatesMember 2024-05-14 0001812727 RELI:StockExchangeAgreementMember RELI:SpetnerAssociatesMember 2024-05-14 2024-05-14 0001812727 RELI:FortmanInsuranceAgencyLLCMember 2023-12-31 0001812727 RELI:SouthwesternMontanaInsuranceCenterIncMember 2023-12-31 0001812727 RELI:AltruisBenefitsConsultantsIncMember 2023-12-31 0001812727 RELI:JPKushAndAssociatesIncMember 2023-12-31 0001812727 RELI:FortmanInsuranceAgencyLLCMember 2024-01-01 2024-06-30 0001812727 RELI:SouthwesternMontanaInsuranceCenterIncMember 2024-01-01 2024-06-30 0001812727 RELI:AltruisBenefitsConsultantsIncMember 2024-01-01 2024-06-30 0001812727 RELI:JPKushAndAssociatesIncMember 2024-01-01 2024-06-30 0001812727 RELI:FortmanInsuranceAgencyLLCMember 2024-06-30 0001812727 RELI:SouthwesternMontanaInsuranceCenterIncMember 2024-06-30 0001812727 RELI:AltruisBenefitsConsultantsIncMember 2024-06-30 0001812727 RELI:JPKushAndAssociatesIncMember 2024-06-30 0001812727 RELI:FortmanInsuranceAgencyLLCMember 2022-12-31 0001812727 RELI:SouthwesternMontanaInsuranceCenterIncMember 2022-12-31 0001812727 RELI:AltruisBenefitsConsultantsIncMember 2022-12-31 0001812727 RELI:JPKushAndAssociatesIncMember 2022-12-31 0001812727 RELI:BarraMember 2022-12-31 0001812727 RELI:FortmanInsuranceAgencyLLCMember 2023-01-01 2023-12-31 0001812727 RELI:SouthwesternMontanaInsuranceCenterIncMember 2023-01-01 2023-12-31 0001812727 RELI:AltruisBenefitsConsultantsIncMember 2023-01-01 2023-12-31 0001812727 RELI:JPKushAndAssociatesIncMember 2023-01-01 2023-12-31 0001812727 RELI:BarraMember 2023-01-01 2023-12-31 0001812727 us-gaap:RelatedPartyMember RELI:EmployeePayablesMember 2024-06-30 0001812727 us-gaap:RelatedPartyMember RELI:EmployeePayablesMember 2023-12-31 0001812727 us-gaap:RelatedPartyMember RELI:EmployeePayablesMember 2024-04-01 2024-06-30 0001812727 us-gaap:RelatedPartyMember RELI:EmployeePayablesMember 2023-04-01 2023-06-30 0001812727 us-gaap:RelatedPartyMember RELI:EmployeePayablesMember 2024-01-01 2024-06-30 0001812727 us-gaap:RelatedPartyMember RELI:EmployeePayablesMember 2023-01-01 2023-06-30 0001812727 us-gaap:RelatedPartyMember RELI:DeferredPurchasePriceLiabilityMember 2024-06-30 0001812727 us-gaap:RelatedPartyMember RELI:DeferredPurchasePriceLiabilityMember 2023-12-31 0001812727 us-gaap:RelatedPartyMember RELI:DeferredPurchasePriceLiabilityMember 2024-04-01 2024-06-30 0001812727 us-gaap:RelatedPartyMember RELI:DeferredPurchasePriceLiabilityMember 2023-04-01 2023-06-30 0001812727 us-gaap:RelatedPartyMember RELI:DeferredPurchasePriceLiabilityMember 2024-01-01 2024-06-30 0001812727 us-gaap:RelatedPartyMember RELI:DeferredPurchasePriceLiabilityMember 2023-01-01 2023-06-30 0001812727 us-gaap:RelatedPartyMember RELI:PurchaseAgreementLiabilityMember 2024-06-30 0001812727 us-gaap:RelatedPartyMember RELI:PurchaseAgreementLiabilityMember 2023-12-31 0001812727 us-gaap:RelatedPartyMember RELI:PurchaseAgreementLiabilityMember 2024-04-01 2024-06-30 0001812727 us-gaap:RelatedPartyMember RELI:PurchaseAgreementLiabilityMember 2023-04-01 2023-06-30 0001812727 us-gaap:RelatedPartyMember RELI:PurchaseAgreementLiabilityMember 2024-01-01 2024-06-30 0001812727 us-gaap:RelatedPartyMember RELI:PurchaseAgreementLiabilityMember 2023-01-01 2023-06-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

     

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549

     

    FORM 10-Q

     

    ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the quarterly period ended June 30, 2024

     

    or

     

    ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

     

    For the transition period from _____ to _____

     

    Commission File Number: 001-40020

     

    RELIANCE GLOBAL GROUP, INC.

    (Exact name of registrant as specified in its charter)

     

    Florida   46-3390293

    (State or other jurisdiction

    of incorporation or organization)

     

    (I.R.S. Employer

    Identification No.)

     

    300 Blvd. of the Americas, Suite 105 Lakewood, NJ 08701

    (Address of principal executive offices) (Zip Code)

     

    732-380-4600

    (Registrant’s telephone number, including area code)

     

    N/A

    (Former name, former address and former fiscal year, if changed since last report)

     

    Securities registered pursuant to Section 12(b) of the Act:

     

    Title of each class   Trading Symbol(s)   Name of each exchange on which registered
    Common Stock   RELI   The Nasdaq Capital Market
    Series A Warrants   RELIW   The Nasdaq Capital Market

     

    Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

     

    Yes ☒ No ☐

     

    Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

     

    Yes ☒ No ☐

     

    Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company, in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ☐ Accelerated filer ☐
    Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☐  

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

     

    Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act).

     

    Yes ☐ No ☒

     

    At July 25, 2024, the registrant had 1,239,407 shares of common stock, par value $0.086 per share, outstanding.

     

     

     

     

     

     

    TABLE OF CONTENTS

     

    PART I  
    Item 1. Financial Statements 3
    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 19
    Item 3. Quantitative and Qualitative Disclosures About Market Risk. 26
    Item 4. Controls and Procedures. 26
    PART II  
    Item 1. Legal Proceedings. 27
    Item 1A. Risk Factors. 27
    Item 2. Unregistered Sales of Equity Securities and Use of Proceeds. 27
    Item 3. Defaults Upon Senior Securities. 28
    Item 4. Mine Safety Disclosures. 28
    Item 5. Other Information. 28
    Item 6. Exhibits 28

     

    2

     

     

    Reliance Global Group, Inc. and Subsidiaries

    Condensed Consolidated Balance Sheets

    (Unaudited)

     

       June 30,   December 31, 
       2024   2023 
    Assets          
    Current assets:          
    Cash  $1,405,824   $1,329,016 
    Restricted cash   1,409,787    1,409,895 
    Accounts receivable   945,823    1,298,863 
    Accounts receivable, related parties   7,451    6,603 
    Accounts receivable   7,451    6,603 
    Other receivables   167,292    899 
    Prepaid expense and other current assets   385,987    333,756 
    Total current assets   4,322,164    4,379,032 
               
    Property and equipment, net   140,483    139,999 
    Right-of-use assets   1,013,703    739,830 
    Intangibles, net   6,152,752    11,042,757 
    Goodwill   6,693,099    6,693,099 
    Other non-current assets   21,791    20,292 
    Total assets  $18,343,992   $23,015,009 
               
    Current liabilities:          
    Accounts payable and other accrued liabilities  $1,420,697   $835,483 
    Short term financing agreements   108,525    56,197 
    Current portion of loans payables, related parties   443,853    454,953 
    Other payables   14,434    7,414 
    Current portion of long-term debt   1,471,233    1,390,766 
    Current portion of leases payable   263,369    285,171 
    Earn-out liability, current portion   -    159,867 
    Total current liabilities   3,722,111    3,189,851 
               
    Loans payable, related parties, less current portion   660,875    897,529 
    Long term debt, less current portion   10,289,853    11,026,971 
    Leases payable, less current portion   781,586    484,335 
    Warrant liabilities   326    268,993 
    Total liabilities   15,454,751    15,867,679 
               
    Stockholders’ equity:          
    Preferred stock, $0.086 par value; 750,000,000 shares authorized and 0 issued and outstanding as of June 30, 2024 and December 31, 2023, respectively   -    - 
    Common stock, $0.086 par value; 117,647,059 shares authorized and 1,037,027 and 280,117 issued and outstanding as of June 30, 2024 and December 31, 2023, respectively   89,184    24,089 
    Additional paid-in capital   48,638,079    46,125,206 
    Accumulated deficit   (45,838,022)   (39,001,965)
    Total stockholders’ equity   2,889,241    7,147,330 
    Total liabilities and stockholders’ equity  $18,343,992   $23,015,009 

     

    The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

     

    3

     

     

    Reliance Global Group, Inc. and Subsidiaries

    Condensed Consolidated Statements of Operations

    (Unaudited)

     

       2024   2023   2024   2023 
      

    Three Months Ended June 30,

      

    Six Months Ended June 30,

     
       2024   2023   2024   2023 
    Revenue                    
    Commission income  $3,233,342   $3,195,905   $7,315,780   $7,135,008 
    Total revenue   3,233,342    3,195,905    7,315,780    7,135,008 
                         
    Operating expenses                    
    Commission expense   886,364    829,274    2,162,905    1,912,600 
    Salaries and wages   1,955,152    1,771,064    3,786,814    3,526,957 
    General and administrative expenses   991,633    1,125,211    2,366,523    1,962,978 
    Marketing and advertising   76,983    109,860    204,025    246,432 
    Change in estimated acquisition earn-out payables   -    543,233    47,761    1,019,925 
    Depreciation and amortization   469,788    655,449    1,003,941    1,309,227 
    Asset impairments   -    -    3,922,110    - 
    Total operating expenses   4,379,920    5,034,091    13,494,079    9,978,119 
                         
    Loss from operations   (1,146,578)   (1,838,186)   (6,178,299)   (2,843,111)
                         
    Other (expense) income                    
    Interest expense   (365,970)   (370,905)   (735,646)   (722,462)
    Interest expense, related parties   (37,525)   (51,153)   (78,134)   (92,629)
    Interest expense   (37,525)   (51,153)   (78,134)   (92,629)
    Other income (expense), net   11    (16,979)   22    (13,297)
    Recognition and change in fair value of warrant liabilities   60,667    (1,592,509)   156,000    2,673,723 
    Total other (expense) income   (342,817)   (2,031,546)   (657,758)   1,845,335 
                         
    Loss from continuing operations before tax   (1,489,395)   (3,869,732)   (6,836,057)   (997,776)
    Income (loss) from discontinued operations before tax   -    2,814,445    -    (1,846,048)
    Net loss  $(1,489,395)  $(1,055,287)  $(6,836,057)  $(2,843,824)
                         
    Basic (loss) earnings per share                    
    Continuing operations  $ (2.76)  $(24.21)  $ (14.77)  $(7.93)
    Discontinued operations  $ -   $17.61   $ -   $(14.68)
    Basic (loss) earnings per share  $ (2.76)  $(6.60)  $ (14.77)  $(22.61)
                         
    Diluted (loss) earnings per share                    
    Continuing operations  $ (2.76)  $(24.21)  $ (14.77

    )

      $(7.93)
    Discontinued operations  $ -   $17.61  $ -   $(14.68)
    Diluted (loss) earnings per share  $ (2.76)  $(6.60)  $ (14.77)  $(22.61)
                         
    Weighted average number of shares outstanding - Basic   539,133    159,795    462,773    125,791 
    Weighted average number of shares outstanding - Diluted   539,133    159,795    462,773    125,791 

     

    The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

     

    4

     

     

    Reliance Global Group, Inc. and Subsidiaries

    Condensed Consolidated Statements of Stockholders’ Equity

    (Unaudited)

     

       Shares   Amount   capital   Deficit   Total 
       Common Stock  

    Additional

    Paid-in

       Accumulated     
       Shares   Amount   capital   Deficit   Total 
                         
    Balance, December 31, 2023   280,117   $24,089   $46,125,206   $(39,001,965)  $7,147,330 
                              
    Common share payments for earn-outs   -         17,628    -    17,628 
                       -    - 
    Common shares issued for ATM share sales   11,036    949    123,699         124,648 
                       -      
    Common shares issued for abeyance share conversions   42,545    3,659    (3,659)        - 
                       -      
    Common share-based compensation   1,149    99    18,466    -    18,565 
                              
    Net loss   -    -    -    (5,346,663)   (5,346,663)
                              
    Balance, March 31, 2024   334,847   $28,796   $46,281,340   $(44,348,628)  $1,961,508 
                              
    Common share payments for earn-outs   30,029    2,582    (2,582)   -    - 
                              
    Common shares issued for ATM share sales   302,677    26,032    1,917,664    -    1,943,696
                              
    Common shares issued for abeyance share conversions   59,471    5,115    (5,115)   -    - 
                              
    Common shares issued for Series B warrants   39,569    3,403    109,263    -    112,666 
                              
    Common shares issued for Series G warrants   192,236    16,532    (16,532)   -    - 
                              
    Common share-based compensation   60,373    5,192    240,574    -    245,766 
                              
    Common shares issued for services   17,825    1,533    113,467    -    115,000 
                              
    Net loss   -    -    -    (1,489,395)   (1,489,395)
                              
    Balance, June 30, 2024   1,037,027   $89,184   $48,638,079   $(45,838,022)  $2,889,241 

     

    5

     

     

       Shares   Amount   capital   Deficit   Total 
       Common Stock  

    Additional

    Paid-in

       Accumulated     
       Shares   Amount   Capital   Deficit   Total 
                         
    Balance, December 31, 2022   71,740   $6,170   $35,896,852   $(26,991,983)  $8,911,039 
                              
    Common share payments for earn-outs   6,433    553    981,925    -    982,478 
                              
    Common share payments for related party convertible debt   3,926    338    644,662    -    645,000 
                              
    Common shares issued for reverse stock split round up   902    77    (4,723)   -    (4,646)
                              
    Common shares issued in 2023 private placement   9,120    784    3,445,700    -    3,446,484 
                              
    Common share-based compensation   -    -    43,797    -    43,797 
                              
    Net loss   -    -    -    (1,788,538)   (1,788,538)
                              
    Balance, March 31, 2023   92,121   $7,922   $41,008,213   $(28,780,521)  $12,235,614 
    Balance   92,121   $7,922   $41,008,213   $(28,780,521)  $12,235,614 
                              
    Common shares issued for services   6,621    570    377,425    -    377,995 
                              
    Common share payments for earn-outs   20,721    1,782    1,431,918    -    1,433,700 
                              
    Common shares issued for vested stock awards   1,307    112    (112)   -    - 
                              
    Common share-based compensation   -    -    35,367    -    35,367 
                              
    Net loss   -    -    -    (1,055,287)   (1,055,287)
                              
    Balance, June 30, 2023   120,770   $10,387   $42,852,810   $(29,835,808)  $13,027,389 
    Balance   120,770   $10,387   $42,852,810   $(29,835,808)  $13,027,389 

     

    The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

     

    6

     

     

    Reliance Global Group, Inc. and Subsidiaries and Predecessor

    Condensed Consolidated Statements of Cash Flows

    (Unaudited)

     

       2024   2023 
       Six Months Ended June 30, 
       2024   2023 
    CASH FLOWS FROM OPERATING ACTIVITIES:          
    Net loss  $(6,836,057)  $(2,843,824)
    Adjustment to reconcile net income to net cash used in operating activities:          
    Depreciation and amortization   1,003,941    1,309,227 
    Asset impairments   3,922,110    - 
    Amortization of debt issuance costs and accretion of debt discount   23,442    23,442 
    Non-cash lease expense (income)   1,574    (4,355)
    Equity based compensation expense   264,331    79,164 
    Equity based payments to service providers   224,477    377,995 
    Recognition and change in fair value of warrant liability   (156,000)   (2,673,723)
    Earn-out fair value and write-off adjustments   47,761    1,019,925 
    Change in operating assets and liabilities:          
    Accounts receivable   353,040    15,444 
    Accounts receivable, related parties   (847)   (1,072)
    Other receivables   (166,393)   10,816 
    Prepaid expense and other current assets   (161,708)   (303,322)
    Other non-current assets   (1,500)   - 
    Accounts payables and other accrued liabilities   585,215    (40,135)
    Other payables   7,020    115,988 
    Net cash used in continuing operating activities   (889,594)   (2,914,430)
               
    Net cash adjustments for discontinued operating activities   -    907,329 
               
    Total net cash used in continuing and discontinued operating activities   (889,594)   (2,007,101)
               
    CASH FLOWS FROM INVESTING ACTIVITIES:          
    Proceeds from sale of investment in NSURE   -    900,000 
    Purchase of property and equipment   (15,397)   (13,010)
    Purchase of intangibles   (21,134)   (151,862)
    Net cash (used in) provided by investing activities   (36,531)   735,128 
               
    CASH FLOWS FROM FINANCING ACTIVITIES:          
    Principal repayments of debt   (680,093)   (450,935)
    Principal repayments of short-term financings   (106,460)     
    Proceeds from short-term financings   158,788    58,707 
    Payments of loans payable, related parties   (437,754)   (649,870)
    Proceeds from common shares issued through an at the market offering   2,068,344    - 
    Earn-out liability payments   -    (344,225)
    Proceeds from private placement of shares and warrants   -    3,446,484 
    Net cash provided by continuing financing activities   1,002,825    2,060,161 
               
    Net cash used in discontinued financing activities   -    (17,701)
               
    Total net cash provided by continuing and discontinued financing activities   1,002,825    2,042,460 
               
    Net increase in cash and restricted cash   76,700    770,487 
    Cash and restricted cash at beginning of year   2,738,911    1,909,769 
    Cash and restricted cash at end of year  $2,815,611   $2,680,256 

     

    The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

     

    7

     

     

    Reliance Global Group, Inc. and Subsidiaries

    Notes to the Unaudited Condensed Consolidated Financial Statements

     

    NOTE 1. SUMMARY OF BUSINESS AND SIGNIFICANT ACCOUNTING POLICIES

     

    Reliance Global Group, Inc., formerly known as Ethos Media Network, Inc. (“RELI”, “Reliance”, or the “Company”), was incorporated in Florida on August 2, 2013.

     

    Basis of Presentation and Principles of Consolidation

     

    The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America (“U.S. GAAP”) for interim financial information and with the instructions for Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by U.S. GAAP for complete financial statements. In the opinion of management, all adjustments (consisting of recurring accruals) necessary for a fair presentation have been included. These unaudited condensed consolidated financial statements should be read in conjunction with the audited consolidated financial statements and the notes thereto, set forth in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023 (the “Form 10-K”), as the same may be amended from time to time. Capitalized terms not defined in this Quarterly Report on Form 10-Q refer to capitalized terms as defined in the Form 10-K. Certain prior period accounts and balances in these unaudited condensed consolidated financial statements and notes thereto have been reclassified to conform to the current period’s presentation.

     

    The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All intercompany transactions and balances have been eliminated in consolidation.

     

    Liquidity

     

    As of June 30, 2024, the Company’s reported cash and restricted cash aggregated balance was approximately $2,816,000, current assets were approximately $4,322,000, and current liabilities were approximately $3,722,000. As of June 30, 2024, the Company had working capital of approximately $600,000 and stockholders’ equity of approximately $2,889,000. For the six months ended June 30, 2024, the Company had a loss from operations of approximately $6,178,000, which includes a non-cash asset impairment loss of approximately $3,922,000, and net loss of approximately $6,836,000. During the first quarter of 2024, the Company entered into an At Market Issuance Sales Agreement (the “ATM Agreement”) with EF Hutton LLC (the “Agent”), pursuant to which the Company may offer and sell, from time to time, through the Agent, shares of its common stock having an approximate aggregate remaining offering price of up to $1,728,825 as of the date of filing of this Quarterly Report on Form 10-Q.

     

    Although there can be no assurance that debt or equity financing will be available on acceptable terms, or at all, the Company believes its financial position and its ability to raise capital to be reasonable and sufficient. Based on our assessment, we do not believe there are conditions or events that, in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern within one year of filing these unaudited financial statements with the Securities and Exchange Commission (“SEC”).

     

    Use of Estimates

     

    The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosures in the financial statements and accompanying notes. Management bases its estimates on historical experience and on assumptions believed to be reasonable under the circumstances. Actual results could differ materially from those estimates.

     

    8

     

     

    Cash and Restricted Cash

     

    Cash and restricted cash reported on our condensed consolidated balance sheets are reconciled to the total shown on our condensed consolidated statements of cash flows as follows:

     

    SCHEDULE OF RESTRICTED CASH IN STATEMENT OF CASH FLOW

       June 30, 2024   June 30, 2023 
    Cash  $1,405,824   $1,274,743 
    Restricted cash   1,409,787    1,405,513 
    Total cash and restricted cash  $2,815,611   $2,680,256 

     

    Fair Value of Financial Instruments

     

    Level 1 — Observable inputs reflecting quoted prices (unadjusted) in active markets for identical assets and liabilities;

     

    Level 2 — Inputs other than quoted prices in active markets for identical assets and liabilities that are observable either directly or indirectly for substantially the full term of the asset or liability; and

     

    Level 3 — Unobservable inputs for the asset or liability, which include management’s own assumption about the assumptions market participants would use in pricing the asset or liability, including assumptions about risk.

     

    Warrant Liabilities: The Company re-measures the fair value of its material Level 3 warrant liabilities at the balance sheet date, or at interim dates as applicable for warrant exercise transactions that may occur, using a binomial option pricing model. The following summarizes the significant unobservable inputs for valuations occurring during the periods ended:

     

    SCHEDULE OF WARRANT LIABILITY

       June 30, 2024   December 31, 2023 
    Stock price  $3.74   $9.18 
    Volatility   135.00%   110.00%
    Time to expiry   4.53    4.99 
    Dividend yield   0%   0%
    Risk free rate   4.30%   3.80%
    Warrants measurement input   4.30%   3.80%

     

    The following reconciles fair value of the liability classified warrants:

     

    SCHEDULE OF RECONCILES FAIR VALUE OF LIABILITY CLASSIFIED WARRANTS

      

    Series B

    Warrant

    Liabilities

      

    Placement

    Agent Warrants

       Total 
    Beginning balance, December 31, 2023  $268,667   $326   $268,993 
    Unrealized gain   (95,333)   -    (95,333)
    Warrants exercised or exchanged   -    -    - 
    Ending balance, March 31, 2024  $173,334   $326   $173,660 
    Balance  $173,334   $326   $173,660 
    Unrealized gain   (60,667)   -    (60,667)
    Warrants exercised or exchanged   (112,667)   -    (112,667)
    Ending balance, June 30, 2024  $-   $326   $326 
    Balance  $-   $326   $326 

     

    Earn-out liabilities: The Company utilizes two valuation methods to value its Level 3 earn-out liabilities: (a) the income valuation approach, and (b) the Monte Carlo simulation method. Key valuation and unobservable inputs for the income valuation approach include contingent payment arrangement terms, projected revenues and cash flows, rates of return, discount rates and probability assessments.

     

    9

     

     

    The following table summarizes the significant unobservable inputs used in the fair value measurements:

     SCHEDULE OF FAIR VALUE MEASUREMENTS  

       June 30, 2024  December 31, 2023
    Valuation technique  N/A  Discounted cash flow
    Significant unobservable input  N/A  Projected revenue and probability of achievement

     

    The Company values its Level 3 earn-out liability related to the Barra Acquisition using a Monte Carlo simulation in a risk-neutral framework (a special case of the Income Approach). The following summarizes the significant unobservable inputs:

     

    The following table reconciles fair value of earn-out liabilities for the periods ended June 30, 2024, and December 31, 2023:

     

    SCHEDULE OF GAIN OR LOSSES RECOGNIZED FAIR VALUE

       June 30, 2024   December 31, 2023 
    Beginning balance – January 1  $159,867   $2,709,478 
               
    Acquisitions and settlements   -    (3,260,403)
               
    Period adjustments:          
    Fair value changes included in earnings*   47,761    1,716,873 
    Earn-out payable in common shares   (17,628)   (159,867)
    Earn-out transferred to loans payable, related parties   -    (846,214)
    Earn-out payments   (190,000)   - 
    Ending balance   -    159,867 
    Less: Current portion   -    (159,867)
    Ending balance, less current portion  $-   $- 

     

    * Recorded in the change in estimated acquisition earn-out payables caption on the condensed consolidated statements of operations.

     

    Revenue Recognition

     

    The following table disaggregates the Company’s revenue by line of business, showing commissions earned:

     

    SCHEDULE OF DISAGGREGATION REVENUE

    Three Months ended June 30, 2024  Medical   Life   Property and Casualty   Disaggregates revenue 
    Three Months Ended June 30, 2024  Medical   Life   Property and Casualty   Total 
                     
    Three months ended June 30, 2024  $2,389,845   $38,744   $804,753   $3,233,342 
    Three months ended June 30, 2023  $2,526,713   $71,980   $597,212   $3,195,905 
    Six months ended June 30, 2024  $5,715,662   $94,961   $1,505,157   $7,315,780 
    Six months ended June 30, 2023  $5,822,458   $105,604   $1,206,946   $7,135,008 

     

    The following are customers representing 10% or more of total revenue:

     

    SCHEDULE OF CONCENTRATIONS OF REVENUES

    Insurance Carrier  2024   2023 
       Three Months Ended June 30, 
    Insurance Carrier  2024   2023 
    Priority Health   22%   28%
    BlueCross BlueShield   11%   12%
    Insurance carrier   11%   12%

     

    10

     

     

    Insurance Carrier  2024   2023 
       Six Months Ended June 30, 
    Insurance Carrier  2024   2023 
    Priority Health   35%   37%
    BlueCross BlueShield   12%   13%
    Insurance carrier   12%   13%

     

    No other single customer accounted for more than 10% of the Company’s commission revenues during the three and six months ended June 30, 2024 and 2023. The loss of any significant customer could have a material adverse effect on the Company.

     

    Income Taxes

     

    The Company recorded no income tax expense for the three and six months ended June 30, 2024 and 2023 because the estimated annual effective tax rate was zero. In determining the estimated annual effective income tax rate, the Company analyzes various factors, including projections of the Company’s annual earnings and taxing jurisdictions in which the earnings will be generated, the impact of state and local income taxes, the ability to use tax credits and net operating loss carry forwards, and available tax planning alternatives.

     

    As of June 30, 2024 and December 31, 2023, the Company provided a full valuation allowance against its net deferred tax assets, since the Company believes it is more likely than not that its deferred tax assets will not be realized.

     

    Recently Issued Accounting Pronouncements

     

    We do not expect any recently issued accounting pronouncements to have a material effect on our financial statements not already disclosed in the Form 10-K.

     

    NOTE 2. GOODWILL AND OTHER INTANGIBLE ASSETS

     

    The following table rolls forward the Company’s goodwill balance for the periods ended June 30, 2024, and December 31, 2023, adjusted for discontinued operations.

     

    SCHEDULE OF IMPAIRMENT OF GOODWILL

       Goodwill 
    December 31, 2022  $14,287,099 
    Goodwill impairment recognized as of December 31, 2023   (7,594,000)
    December 31, 2023   6,693,099 
    June 30, 2024  $6,693,099 

     

    Asset Impairments:

     

    During the quarter ended March 31, 2024, certain intangible assets stemming from discontinued operations which were originally transferred to the Company’s operating entity, were determined to have carrying values exceeding fair value, and thus were considered impaired. These intangible assets consisted of customer relationships, and internally developed and purchased software, with respective net of accumulated amortization asset values of $3,802,438, $65,411, and $54,261. The write-offs resulted in a total asset impairment charge of $3,922,110, recorded in the asset impairment account on the unaudited condensed consolidated statements of operations for the six-month period ended June 30, 2024.

     

    11

     

     

    The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of June 30, 2024:

    SCHEDULE OF INTANGIBLE ASSETS AND WEIGHTED-AVERAGE REMAINING AMORTIZATION PERIOD

     

      

    Weighted

    Average Remaining Amortization

    Period

    (Years)

      

    Gross

    Carrying Amount

      

    Accumulated

    Amortization

      

    Net Carrying

    Amount

     
    Trade name and trademarks  1.0   $1,807,188   $(1,487,205)  $319,983 
    Internally developed software  2.7    1,698,186    (773,371)   924,815 
    Customer relationships  6.3    7,372,290    (2,813,315)   4,558,975 
    Purchased software  2.0    564,396    (563,074)   1,322 
    Video production assets  -    50,000    (50,000)   - 
    Non-competition agreements  0.4    3,504,810    (3,157,153)   347,657 
           $14,996,870   $(8,844,118)  $6,152,752 

     

    The following table sets forth the major categories of the Company’s intangible assets and the weighted-average remaining amortization period as of December 31, 2023:

     

      

    Weighted

    Average Remaining Amortization

    period

    (Years)

      

    Gross

    Carrying Amount

      

    Accumulated

    Amortization

      

    Net Carrying

    Amount

     
    Trade name and trademarks  1.5   $1,807,189   $(1,320,939)  $486,250 
    Internally developed software  3.2    1,798,922    (650,029)   1,148,893 
    Customer relationships  8.0    11,922,290    (3,193,629)   8,728,661 
    Purchased software  0.3    667,206    (618,418)   48,788 
    Video production assets  -    50,000    (50,000)   - 
    Non-competition agreements  0.9    3,504,810    (2,874,645)   630,165 
          $19,750,417   $(8,707,660)  $11,042,757 

     

    The following table reflects expected amortization expense as of June 30, 2024, for each of the following five years and thereafter:

     

    SCHEDULE OF AMORTIZATION EXPENSE OF ACQUIRED INTANGIBLES ASSETS

    Years Ending December 31,  Amortization Expense 
    2024 (remaining six months)  $764,453 
    2025   1,397,041 
    2026   1,148,216 
    2027   807,696 
    2028   717,314 
    Thereafter   1,318,032 
    Total  $6,152,752 

     

    12

     

     

    NOTE 3. LONG-TERM DEBT AND SHORT-TERM FINANCINGS

     

    Long-Term Debt

     

    The composition of the long-term debt is as follows:

     

    SCHEDULE OF LONG TERM DEBT

      

    June 30,

    2024

      

    December 31,

    2023

     
             
    Oak Street Funding LLC Term Loan   $338,812   $369,602 
    Oak Street Funding LLC Term Loan for the acquisition of EBS and USBA, variable interest of prime rate plus 2.5%, maturing August 2028, net of deferred financing costs of $9,060 and $10,069 as of June 30, 2024 and December 31, 2023, respectively  $338,812   $369,602 
    Oak Street Funding LLC Senior Secured Amortizing Credit Facility for the acquisition of CCS, variable interest of prime rate plus 1.5%, maturing December 2028, net of deferred financing costs of $11,250 and $12,525 as of June 30, 2024, and December 31, 2023, respectively   557,497    604,830 
    Oak Street Funding LLC Term Loan for the acquisition of SWMT, variable interest of prime rate plus 2.0%, maturing April 2029, net of deferred financing costs of $6,997 and $7,733 as of June 30, 2024 and December 31, 2023, respectively   646,205    695,758 
    Oak Street Funding LLC Term Loan for the acquisition of FIS, variable interest of prime rate plus 2.0%, maturing May 2029, net of deferred financing costs of $28,117 and $31,026 as of June 30, 2024 and December 31, 2023, respectively   1,636,131    1,758,558 
    Oak Street Funding LLC Term Loan for the acquisition of ABC, variable interest of prime rate plus 2.0%, maturing September 2029, net of deferred financing costs of $32,409 and $35,649 as of June 30, 2024 and December 31, 2023, respectively   2,712,692    2,899,409 
    Oak Street Funding LLC Term Loan for the acquisition of Barra, variable interest of prime rate plus 2.5%, maturing May 2032, net of deferred financing costs of $166,049 and $176,762 as of June 30, 2024 and December 31, 2023, respectively   5,869,749    6,089,580 
     Long term debt gross    11,761,086    12,417,737 
    Less: current portion   (1,471,233)   (1,390,766)
    Long-term debt  $10,289,853   $11,026,971 

     

    Oak Street Funding LLC – Term Loans and Credit Facilities

     

    SCHEDULE OF CUMULATIVE MATURITIES OF LONG -TERM LOANS AND CREDIT FACILITIES

    Years Ending December 31, 

    Maturities of

    Long-Term Debt

     
    2024 (remaining six months)  $714,133 
    2025   1,552,772 
    2026   1,729,160 
    2027   1,925,603 
    2028   2,106,978 
    Thereafter   3,986,322 
    Total   12,014,968 
    Less: debt issuance costs   (253,882)
    Total  $11,761,086 

     

    13

     

     

    Short-Term Financings

     

    The Company has various short-term notes payable for financed items such as insurance premiums. These are normally paid in equal installments over a period of twelve months or less and carry interest rates ranging between 7.95% and 11.95% per annum. As of June 30, 2024, and December 31, 2023, balances outstanding on short-term financings were $108,525 and $56,197, respectively.

     

    NOTE 4. WARRANT LIABILITIES

     

    Series B Warrants and PAW’s

     

    On June 18, 2024, the holder of the remaining Series B Warrants exercised all their remaining 50,980 warrants via cashless exercises, thereby acquiring 39,569 shares of the Company’s common stock, $0.086 par value per share. The Series B Warrants effective exercise price per share as of the date of the exercises was $3.91.

     

    For the three and six months ended June 30, 2024, net fair value gains and losses recognized for the Series B Warrants and PAW’s, were gains of $60,667 and $156,000, respectively, whereas for the three and six months ended June 30, 2023, net fair value gains and losses recognized were a loss of $1,592,509 and a gain of $2,673,723, respectively, presented in the recognition and change in fair value of warrant liabilities account in the unaudited consolidated statements of operations.

     

    As of June 30, 2024, there were 0 and 959 Series B Warrants and PAW’s outstanding respectively, with respective fair values of $0 and $326, presented in the warrant liability account on the condensed consolidated balance sheets. As of June 30, 2023, there were 78,383 and 959 Series B Warrants and PAW’s outstanding, with respective fair values of $3,741,983 and $326, presented in the warrant liability account on the unaudited condensed consolidated balance sheets.

     

    NOTE 5. EQUITY

     

    Common Stock

     

    The Company is authorized to issue 117,647,059 shares of common stock, $0.086 par value. Each share of issued and outstanding common stock entitles the holder thereof to fully participate in all shareholder meetings, to cast one vote on each matter with respect to which shareholders have the right to vote, and to share ratably in all dividends and other distributions declared and paid with respect to common stock, as well as in the net assets of the Company upon liquidation or dissolution.

     

    During the first quarter of 2024, the Company issued 11,036 shares through its ATM program, 42,545 pursuant to abeyance share conversions and 1,149 shares for equity-based compensation.

     

    On July 1, 2024, the Company effectuated a 1-for-17 reverse stock split of the Company’s issued and outstanding common stock (the “Reverse Split-2024”). The par value remained unchanged following the Reverse Split-2024. All share and per share information as well as common stock and additional paid-in capital have been retroactively adjusted to reflect the Reverse Split-2024 for all periods presented, unless otherwise indicated. The Reverse Split-2024 resulted in a rounding addition of approximately 110,350 shares valued at par, totaling $9,490 for which shares were issued in July 2024.

     

    During the second quarter of 2024, the Company issued 302,677 shares through its ATM program, 59,471 pursuant to abeyance share conversions, 60,373 shares for equity-based compensation, 30,029 shares for repayment of an earn-out liability, 39,569 shares on the exercise of Series B warrants, 192,236 shares for the exercise of Series G warrants, and 17,825 shares for service rendered.

     

    As of June 30, 2024, and December 31, 2023, there were 1,037,027 and 280,117 shares of common stock outstanding, respectively.

     

    Abeyance Shares

     

    During the first and second quarters of 2024 respectively, upon request from an institutional investor, the Company converted 42,545 and 59,471 abeyance shares into common stock, thereby issuing 42,545 and 59,471 common shares, resulting in zero abeyance shares outstanding as of June 30, 2024.

     

    Series G Warrants

     

    Pursuant to the terms of the Series G Warrants, during the second quarter of 2024, the Series G Warrant exercise price reset from $11.16 per share to $3.96 per share, as a result of sales of our common stock pursuant to the ATM Agreement discussed below. On June 18, 2024, the holder of the Series G Warrants exercised all of its 247,678 warrants, via cashless exercises, thereby acquiring 192,236 shares of the Company’s common stock, which resulted in no remaining Series G Warrants outstanding as of June 30, 2024.

     

    14

     

     

    At Market Program (the “ATM”)

     

    On February 15, 2024, the Company entered into the ATM Agreement with the Agent, pursuant to which the Company may offer and sell, from time to time through the Agent, shares of its common stock having an aggregate maximum offering price as determined by the then in effect prospectus supplement to the base prospectus included in the registration statement (the “ATM Capacity”). Any shares offered and sold in the ATM offering will be issued pursuant to the Company’s effective shelf registration statement on Form S-3 (File No. 333-275190), which was declared effective by the SEC on November 7, 2023, and related prospectus supplements and accompanying base prospectus relating to the ATM offering. Under the Agreement, the Agent may sell shares by any method permitted by law and deemed to be an “at-the-market” offering as defined in Rule 415 promulgated under the Securities Act of 1933, as amended (the “Securities Act”). The offering of shares pursuant to the ATM Agreement will terminate upon the earlier of (i) the sale of all of the shares subject to the ATM Agreement, or (ii) the termination of the ATM Agreement by the Agent or the Company, as permitted therein. The Company agreed to pay to the Agent in cash, upon each sale of shares pursuant to the ATM Agreement, an amount equal to 3.5% of the gross proceeds from each such sale. The Company agreed to reimburse the Agent for certain specified expenses in connection with entering into the ATM Agreement.

     

    During the six months ended June 30, 2024, the Company sold 313,713 shares of common stock under the ATM Agreement, at an average price of $5.3492, receiving proceeds, net of $141,631 in agent commissions and legal and other fees, of $2,068,344. From the net sale proceeds, $146,174 was received in July 2024 and is recorded in the other receivables account in the unaudited condensed consolidated balance sheets as of June 30, 2024.As of the date of filing of this Quarterly Report on Form 10-Q, the net remaining ATM Capacity was $1,728,825.

     

    Equity-based Compensation

     

    Total stock-based compensation expense recorded in the unaudited condensed consolidated statements of operations for the three months ended June 30, 2024, and 2023 was $245,766 and $35,367, respectively. Total stock-based compensation expense recorded in the unaudited condensed consolidated statements of operations for the six months ended June 30, 2024 and 2023 was $264,331 and $79,164, respectively.

     

    NOTE 6. EARNINGS (LOSS) PER SHARE

     

    Basic earnings per common share (“EPS”) applicable to common stockholders is computed by dividing earnings applicable to common stockholders by the weighted-average number of common shares outstanding.

     

    If there is a loss from operations, diluted EPS is computed in the same manner as basic EPS is computed. Similarly, if the Company has net income but its preferred dividend adjustment made in computing income available to common stockholders results in a net loss available to common stockholders, diluted EPS would be computed in the same manner as basic EPS.

     

    The following calculates basic and diluted EPS:

     

    SCHEDULE OF CALCULATIONS OF BASIC AND DILUTED EPS

       Three Months   Three Months 
       Ended   Ended 
       June 30, 2024   June 30, 2023 
    Loss from continuing operations  $(1,489,395)  $(3,869,732)
    Net loss continuing operations, numerator, basic computation   (1,489,395)   (3,869,732)
    Recognition and change in fair value of warrant liabilities   -    - 
    Net loss from continuing operations, numerator, diluted computation  $(1,489,395)  $(3,869,732)
               
    Weighted average common shares, basic   539,133    159,795 
    Effect of Series B Warrants   -    - 
    Weighted average common shares, dilutive   539,133    159,795 
    Loss per common share – basic  $(2.76)  $(24.21)
    Loss per common share – diluted  $(2.76)  $(24.21)

     

    15

     

     

       Six Months   Six Months 
       Ended   Ended 
       June 30, 2024   June 30, 2023 
    Loss from continuing operations  $(6,836,057)  $(997,776)
    Net Loss continuing operations, numerator, basic computation   (6,836,057)   (997,776)
    Recognition and change in fair value of warrant liabilities   -    - 
    Net loss from continuing operations, numerator, diluted computation  $(6,836,057)  $(997,776)
               
    Weighted average common shares, basic   462,773   125,791 
    Effect of Series B Warrants   -    - 
    Weighted average common shares, dilutive   462,773    125,791 
    Loss per common share – basic  $(14.77)  $(7.93)
    Loss per common share – diluted  $(14.77)  $(7.93)

     

    Additionally, the following are considered anti-dilutive securities excluded from weighted-average shares used to calculate diluted net loss per common share:

     

    SCHEDULE OF DILUTIVE NET LOSS PER COMMON SHARE 

      

    June 30, 2024

      

    June 30, 2023

     
       For the Three Months Ended 
      

    June 30, 2024

      

    June 30, 2023

     
    Shares subject to outstanding common stock options   510    649 
    Shares subject to outstanding Series A warrants   6,647    6,647 
    Shares subject to outstanding PAW’s   

    959

       

    959

    Shares subject to outstanding Series F warrants   -    123,840 
    Shares subject to PA Warrants   3,096    3,096 
    Shares subject to unvested stock awards   52    205 

     

      

    June 30, 2024

      

    June 30, 2023

     
       For the Six Months Ended 
      

    June 30, 2024

      

    June 30, 2023

     
    Shares subject to outstanding common stock options   510    649 
    Shares subject to outstanding Series A warrants   6,647    6,647 
    Shares subject to outstanding PAW’s   959    959 
    Shares subject to outstanding Series F warrants   -    123,840 
    Shares subject to PA Warrants   3,096    3,096 
    Shares subject to unvested stock awards   52    205 

     

    NOTE 7. LEASES

     

    Operating lease expense for the three months ended June 30, 2024, and 2023 was $102,073 and $123,326, respectively. Operating lease expense for the six months ended June 30, 2024, and 2023 was $207,029 and $239,296 respectively. As of June 30, 2024, the weighted average remaining lease term and weighted average discount rate for the operating leases were 5.08 years and 8.35%, respectively.

     

    16

     

     

    Future minimum lease payments under these operating leases consisted of the following:

     

    SCHEDULE OF FUTURE MINIMUM LEASE PAYMENT 

    Fiscal year ending December 31,  Operating Lease Obligations 
    2024 (remaining six months)  $180,322 
    2025   265,399 
    2026   229,522 
    2027   215,325 
    2028   182,190 
    Thereafter   225,136 
    Total undiscounted operating lease payments   1,297,894 
    Less: Imputed interest   (252,939)
    Present value of operating lease liabilities  $1,044,955 

     

    NOTE 8. COMMITMENTS AND CONTINGENCIES

     

    Legal Contingencies

     

    The Company is subject to various legal proceedings and claims, either asserted or unasserted, arising in the ordinary course of business. While the outcome of these claims cannot be predicted with certainty, management does not believe the outcome of any of these matters will have a material adverse effect on our business, financial position, results of operations, or cash flows, and accordingly and no legal contingencies are accrued as of June 30, 2024, and December 31, 2023. Litigation relating to the insurance brokerage industry is not uncommon. As such the Company, from time to time has been subject to such litigation. No assurances can be given with respect to the extent or outcome of any such litigation in the future.

     

    Earn-out liabilities

     

    The Company, Southwestern Montana Insurance Center, LLC, a Montana limited liability company (the “Subsidiary”), Southwestern Montana Financial Center, Inc., a Montana corporation (the “Seller”), and Julie A. Blockey (the “Holder”, and collectively with the Company, Subsidiary, and Seller, the “Parties”) entered into a purchase agreement on or around April 1, 2019 (the “Purchase Agreement”), whereby the Company purchased the business and certain assets noted within the Purchase Agreement. On September 29, 2023, the Parties entered into a first amendment to the Purchase Agreement (the “First Amendment”). Pursuant to the First Amendment, the Parties agreed to a total remaining earn-out related balance of $500,000 owed under the Purchase Agreement. In satisfaction of such remaining balance, the Company agreed to issue 10,272 shares of the Company’s restricted common stock, par value $0.086 per share (the “Common Stock”), to the Holder. The First Amendment also stated that if the Nasdaq official closing price of the Common Stock is less than $41.31 on March 29, 2024 (the “Calculation Date”), then a determination of the Make-Up Amount (as defined herein) will be made. The “Make-Up Amount” means $425,000 minus the Blockey Shares Value (10,272 multiplied by the Nasdaq official closing price of the Common Stock on the Calculation Date). The First Amendment further stated that the Company shall pay the Make-Up Amount with a combination of cash and Company shares. Accordingly, on the Calculation Date, a total Make-Up Amount of $367,496 was determined, and as agreed upon by the Parties, will be payable, $190,000 in cash, and the remaining balance via the issuance of 30,029 of the Company’s Common Stock, subsequently issued to the Seller during April, 2024. The $190,000 cash balance was paid during the quarter ended June 30, 2024.

     

    The following outlines changes to the Company’s earn-out liability balances for the respective periods ended June 30, 2024 and December 31, 2023:

     

    SCHEDULE OF EARN-OUT LIABILITY

       Fortman   Montana   Altruis   Kush   Barra   Total 
    Ending balance December 31, 2023  $-   $159,867   $-   $-   $-   $159,867 
    Payments   -    (190,000

    )

             -         -    -    - 
    Estimates and fair value adjustments   -    47,761    -    -    -    47,761 
    Payable in common stock   -    (17,628)   -    -         -    (17,628)
    Ending balance June 30, 2024  $-   $-   $-   $-   $-   $- 

     

       Fortman   Montana   Altruis   Kush   Barra   Total 
    Ending balance December 31, 2022  $667,000   $500,001   $834,943   $147,534   $560,000   $2,709,478 
    Payments   (1,433,700)   (750,001)   (929,168)   (147,534)   -    (3,260,403)
    Estimates and fair value adjustments   1,612,914    569,734    94,225    -    (560,000)   1,716,873 
    Payable in common stock   -    (159,867)   -    -    -    (159,867)
    Reclass to loans payable, related parties*   (846,214)   -    -    -    -    (846,214)
    Ending balance December 31, 2023  $-   $159,867   $-   $-   $-   $159,867 

     

    * The Company modified certain contingent earn-out payables by entering into fixed payment arrangements. Thus, remaining open balances are reclassified to the loans payable, related parties account on the consolidated balance sheet as of June 30, 2024 and December 31, 2023, respectively.

     

    17

     

     

    Definitive Acquisition Agreements

     

    On May 14, 2024, the Company entered into a Stock Exchange Agreement (the “Stock Exchange Agreement”) to acquire Spetner Associates (“Spetner”). Pursuant to the Stock Exchange Agreement, the Company agreed to: (i) acquire 80% of the issued and outstanding shares of common stock, par value $1.00 per share, of Spetner (the “Spetner Common Stock”) for $13,714,286 (which amount was to be paid as $8,000,000 in cash, the issuance of certain shares of the Company’s common stock, and the Company’s issuance of a promissory note); and (ii) have the sole option to acquire the remaining 20% of Spetner common stock for a predetermined amount based on a multiple of EBITDA.

     

    NOTE 9. RELATED PARTY TRANSACTIONS

     

    The following table summarizes the loans payable, related parties current and non-current accounts, as of the periods ended June 30, 2024 and December 31, 2023, and the interest expense related parties account for the three and six-month periods ended June 30, 2024 and June 30, 2023, as presented on the condensed consolidated balance sheets and condensed consolidated statements of operations, respectively:

    SCHEDULE OF LOANS PAYABLE TO RELATED PARTIES 

       Related Parties Payable   Interest Expense, Related Parties 
       Current Portion   Long Term Portion   for the Three Months Ended   for the Six Months Ended 
    Related Party  June 30, 2024   December 31, 2023   June 30, 2024   December 31, 2023   June 30, 2024   June 30, 2023   June 30, 2024   June 30, 2023 
    Employee Payables   6,127    25,708    -    -    577    1,730    2,307    3,459 
    Deferred Purchase Price Liability   256,173    233,504    111,554    247,055    17,335    49,423    37,167    89,170 
    Purchase Agreement Liability   181,553    195,741    549,321    650,475    19,613    -    38,660    - 
    Total   443,853    454,953    660,875    897,530    37,525    51,153    78,134    92,629 

     

     

    18

     

     

    Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

     

    Overview

     

    Reliance Global Group, Inc. (the “Company”) operates as a diversified company engaging in business in the insurance market, as well as other related sectors. Our focus is to grow the Company by pursuing an aggressive acquisition strategy, initially and primarily focused upon wholesale and retail insurance agencies.

     

    In the insurance sector, our management has extensive experience acquiring and managing insurance portfolios in several states, as well as developing specialized programs targeting niche markets. Our primary strategy is to identify specific risk to reward arbitrage opportunities and develop these on a national platform, thereby increasing revenues and returns, and then identify and acquire undervalued wholesale and retail insurance agencies with operations in growing or underserved segments, expand and optimize their operations, and achieve asset value appreciation while generating interim cash flows.

     

    As part of our growth and acquisition strategy, we continue to survey the current insurance market for value-add acquisition opportunities. As of June 30, 2024, we have acquired nine insurance agencies.

     

    Over the next 12 months, we plan to focus on the expansion and growth of our business through continued asset acquisitions in insurance markets and organic growth of our current insurance operations through geographic expansion and market share growth. To that end, on May 14, 2024, the Company entered into a Stock Exchange Agreement (the “Stock Exchange Agreement”) to acquire Spetner Associates (“Spetner”), a well-established benefits enrollment company that, through its BenManage benefits enrollment company, is a leading provider of voluntary benefits to over 75,000 employees throughout the United States. Pursuant to the Stock Exchange Agreement, the Company agreed to: (i) acquire 80% of Spetner’s issued and outstanding shares of common stock, par value $1.00 per share (the “Spetner Common Stock”) for $13,714,286 (which amount was to be paid as $8,000,000 in cash, the issuance of certain shares of the Company’s common stock, and the Company’s issuance of a promissory note; and (ii) have the sole option to acquire the remaining 20% of the Spetner Common Stock for a predetermined amount based on a multiple of EBITDA

     

    Further, we launched our 5MinuteInsure.com (“5MI”) Insurtech platform during 2021, which expanded our national footprint. 5MI is a high-tech proprietary tool developed by us as a business to consumer portal which enables consumers to instantly compare quotes from multiple carriers and purchase their car and home insurance in a time efficient and effective manner. 5MI taps into the growing number of online shoppers and utilizes advanced artificial intelligence and data mining techniques, to provide competitive insurance quotes in around 5 minutes with minimal data input needed from the consumer. The platform launched during the summer of 2021 and currently operates in 46 states offering coverage with up to 30 highly rated insurance carriers.

     

    With the acquisition of Barra, we launched RELI Exchange, our business-to-business (“B2B”) InsurTech platform and agency partner network that builds on the artificial intelligence and data mining backbone of 5MinuteInsure.com. Through RELI Exchange we on-board agency partners and provide them with an InsurTech platform white labeled, designed and branded specifically for their business. This combines the best of digital and human capabilities by providing our agency partners and their customers quotes from multiple carriers within minutes. Since its inception, RELI Exchange has increased its agent roster by more than 130%.

     

    Business Operations

     

    We’ve adopted a “One-Firm” strategy, pursuant to which Company owned and operated agencies come together to operate as one cohesive unit, which allows for efficient and effective cross-selling, cross-collaboration, and the effective deployment of the Company’s human capital. This strategy also aims to enhance the Company’s overall market presence across the U.S., with all business lines operating under the RELI Exchange brand. It’s expected to benefit agents and clients by improving relationships with carriers, leading to better commission and bonus contracts due to higher business volumes. The approach also strengthens the capability of RELI Exchange agency partners in securing diverse insurance policies and fosters increased cross-selling opportunities. This unified strategy positions the Company for rapid scaling and integration of accretive acquisitions, expanding its industry reach.

     

    19

     

     

    Business Trends and Uncertainties

     

    The insurance intermediary business is highly competitive, and we actively compete with numerous firms for customers and insurance companies, many of which have relationships with insurance companies, or have a significant presence in niche insurance markets that may give them an advantage over us. Other competitive concerns may include the quality of our products and services, our pricing and the ability of some of our customers to self-insure and the entrance of technology companies into the insurance intermediary business. Several insurance companies are engaged in the direct sale of insurance, primarily to individuals, and do not pay commissions to agents and brokers.

     

    Financial Instruments

     

    During the quarter ended June 30, 2024, the Company’s financial instruments consisted of derivative warrants. These were accounted at fair value as of inception/issuance date, and at fair value as of each subsequent balance sheet date. Any change in fair value was recorded as non-operating, (non-cash) gain or loss. As of June 18, 2024, all of the remaining derivative warrants were exercised and there are currently none outstanding.

     

    Insurance Operations

     

    Our insurance operations focus on the acquisition and management of insurance agencies throughout the U.S. Our primary focus is to pinpoint undervalued wholesale and retail insurance agencies with operations in growing or underserved segments (including healthcare and Medicare, as well as personal and commercial insurance lines). We then focus on expanding their operations on a national platform and improving operational efficiencies to achieve asset value appreciation while generating interim cash flows. In the insurance sector, our management team has over 100 years of experience acquiring and managing insurance portfolios in several states, as well as developing specialized programs targeting niche markets. We plan to accomplish these objectives by acquiring wholesale and retail insurance agencies it deems to represent a good buying opportunity (as opposed to insurance carriers) as insurance agencies bear no insurance risk. Once acquired, we plan to develop them on a national platform to increase revenues and profits through a synergetic structure. The Company is initially focused on segments that are underserved or growing, including healthcare and Medicare, as well as personal and commercial insurance lines.

     

    Insurance Acquisitions and Strategic Activities

     

    As of the balance sheet date, we have acquired multiple insurance brokerages (see table below). As our acquisition strategy continues, our reach within the insurance arena can provide us with the ability to offer lower rates, which could boost our competitive position within the industry. In furtherance of this strategy, on May 14, 2024, the Company entered into a Stock Exchange Agreement to acquire Spetner Associates (“Spetner”) for cash, stock and issuance of a promissory note. Spetner is a well-established benefits enrollment company that, through its BenManage benefits enrollment company, is a leading provider of voluntary benefits to over 75,000 employees throughout the United States. Completion of the transaction is subject to standard and stipulated closing.

     

    20

     

     

    Acquired  

    Reliance 100%

    Controlled Entity

      Date   Location   Line of Business
                     
    U.S. Benefits Alliance, LLC (USBA)   US Benefits Alliance, LLC   October 24, 2018   Michigan   Health Insurance
                     
    Employee Benefit Solutions, LLC (EBS)   Employee Benefits Solutions, LLC   October 24, 2018   Michigan   Health Insurance
                     
    Commercial Solutions of Insurance Agency, LLC (CCS or Commercial Solutions)   Commercial Coverage Solutions LLC   December 1, 2018   New Jersey   P&C – Trucking Industry
                     
    Southwestern Montana Insurance Center, Inc. (Southwestern Montana or Montana)   Southwestern Montana Insurance Center, LLC   April 1, 2019   Montana   Group Health Insurance
                     
    Fortman Insurance Agency, LLC (Fortman or Fortman Insurance)   Fortman Insurance Solutions, LLC   May 1, 2019   Ohio   P&C and Health Insurance
                     
    Altruis Benefits Consultants, Inc. (Altruis)   Altruis Benefits Corporation   September 1, 2019   Michigan   Health Insurance
                     
    UIS Agency, LLC (UIS)   UIS Agency, LLC   August 17, 2020   New York   P&C – Trucking Industry
                     
    J.P. Kush and Associates, Inc. (Kush)   Kush Benefit Solutions, LLC   May 1, 2021   Michigan   Health Insurance
                     
    Barra & Associates, LLC   RELI Exchange, LLC   April 26, 2022   Illinois   Health Insurance

     

    Recent Developments

     

    Reverse Stock Split

     

    On July 1, 2024, the Company effectuated a 1-for-17 reverse stock split of the Company’s issued and outstanding common stock (the “Reverse Split-2024”). The par value remained unchanged. All share and per share information, as well as common stock and additional paid-in capital, have been retroactively adjusted to reflect the Reverse Split-2024 for all periods presented, unless otherwise indicated. The Reverse Split-2024 resulted in a rounding addition of approximately 110,350 shares valued at par, totaling $9,490 for which shares were issued in July 2024.

     

    Non-GAAP Measure

     

    The Company believes certain financial measures which meet the definition of non-GAAP financial measures, as defined in Regulation G of the SEC rules, provide important supplemental information. Adjusted EBITDA (“AEBITDA”), our key financial performance metric, is a non-GAAP financial measure that is not in accordance with, or an alternative to, measures prepared in accordance with generally accepted accounting principles in the United States of America (“GAAP”). “AEBITDA” is defined as earnings before interest, taxes, depreciation, and amortization (EBITDA) with additional adjustments as further outlined below. The Company considers AEBITDA an important financial metric because it provides a meaningful financial measure of the quality of the Company’s operational, cash impacted and recurring earnings and operating performance across reporting periods. Other companies may calculate Adjusted EBITDA differently than we do, which might limit its usefulness as a comparative measure to other companies in the industry. AEBITDA is used by management in addition to and in conjunction (and not as a substitute) with the results presented in accordance with GAAP. Management uses AEBITDA to evaluate the Company’s operational performance, including earnings across reporting periods and the merits for implementing cost-cutting measures. We have presented AEBITDA solely as supplemental disclosure because we believe it allows for a more complete analysis of results of operations and assists investors and analysts in comparing our operating performance across reporting periods on a consistent basis by excluding items that we do not believe are indicative of our core operating performance. Consistent with Regulation G, a description of such information is provided below herein and tabular reconciliations of this supplemental non-GAAP financial information to our most comparable GAAP information are contained in this Quarterly Report on Form 10-Q under “Results of Operations”.

     

    21

     

     

    We exclude the following items when calculating AEBITDA, and the following items define our non-GAAP financial measure AEBITDA:

     

      ● Interest and related party interest expense: Unrelated to core Company operations and excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
      ● Depreciation and amortization: Non-cash charge, excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
      ● Goodwill and/or asset impairments: Non-cash charge, excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
      ● Equity-based compensation: Non-cash compensation provided to employees and service providers, excluded to provide more meaningful supplemental information regarding the Company’s core cash impacted operational performance.
      ● Change in estimated acquisition earn-out payables: An earn-out liability is a liability to the seller upon an acquisition which is contingent on future earnings. These liabilities are valued at each reporting period and the changes are reported as either a gain or loss in the change in estimated acquisition earn-out payables account in the consolidated statements of operations. The gain or loss is non-cash, can be highly volatile and overall is not deemed relevant to ongoing operations, thus, it’s excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
      ● Recognition and change in fair value of warrant liabilities: This account includes changes to derivative warrant liabilities which are valued at each reporting period and could result in either a gain or loss. The period changes do not impact cash, can be highly volatile, and are unrelated to ongoing operations, and thus are excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
      ● Other income (expense), net: Includes non-routine income or expenses and other individually de minimis items and is thus excluded as unrelated to core operations of the company.
      ● Transactional costs: This includes expenses related to mergers, acquisitions, financings and refinancings, and amendments or modification to indebtedness. Thes costs are unrelated to primary Company operations and are excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
      ● Non-recuring costs: This account includes non-recurring non-operational items, related to costs incurred for a legal suit the Company has filed against one of the third parties involved in the discontinued operations and was excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.
      ● Loss from discontinued operations before tax: This account includes the net results from discontinued operations, and since discontinued, are unrelated to the Company’s ongoing operations and thus excluded to provide more meaningful supplemental information regarding the Company’s core operational performance.

     

    Refer to the reconciliation of net (loss) income to AEBITDA, illustrated below in tabular format.

     

    22

     

     

    Results of Operations

     

    RELIANCE GLOBAL GROUP, INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF OPERATIONS ANALYTICS

     

    Comparison of the three months ended June 30, 2024 to the three months ended June 30, 2023

     

       June 30, 2024   June 30, 2023   Value Fluctuation   Percent Fluctuation   Explanations
    Commission income  $3,233,342   $3,195,905   $37,437    1%  Increased commission income primarily driven by sustained organic growth.
                            
    Commission expense (“CE”)  886,364    829,274    57,090    7%  Increased CE correlated to growth in revenues.
    Salaries and wages (“S&W”)  1,955,152    1,771,064    184,088    10%  Increased S&W primarily impacted by equity-based pay.
    General and administrative expenses (“G&A”)  991,633    1,125,211    (133,578)   -12%  Decreased G&A was driven by

    leaner operations and OneFirm related cost-cutting measures.

    Marketing and advertising (“M&A”)  76,983    109,860    (32,877)   -30%  M&A decrease consistent with Company’s current marketing strategy.
    Change in estimated acquisition earn-out payables  -    543,233    (543,233)   -100%  Decrease pursuant to the settlement of all earn-out payables.
    Depreciation and amortization (“D&A”)  469,788    655,449    (185,661)   -28%  Decrease due to impaired intangible assets no longer incurring D&A.
                            
    Total operating expenses   4,379,920    5,034,091    (654,171)   -13%   
                  -         
    Loss from operations   (1,146,578)   (1,838,186)   691,908    -38%   
                  -         
    Other income (expense)             -         
    Interest expense   (365,970)   (370,905)   4,935    -1%  Decrease was due to periodic paydowns on loan balances.
    Interest related parties   (37,525)   (51,153)   13,628    -27%  Decrease was due to periodic paydowns on loan balances.
    Other income (expense), net   11    (16,979)   16,990    -100%  Decrease due to certain minor non-recurring and non-significant other income/expense sources.
    Recognition and change in fair value of warrant liabilities   60,667    (1,592,509)   1,653,176    -104%  Fluctuation per fair value changes in derivative warrant liabilities and warrants exercised.
    Total other income (expense)   (342,817)   (2,031,546)   1,688,729    -83%   
                            
    Loss from continuing operations before tax   (1,489,395)   (3,869,732)   2,380,337    -62%   
    Income from discontinued operations before tax   -    2,814,445    (2,814,445)   -100%  Discontinued operations did not re-occur during 2024.
    Net income (loss)  $(1,489,395)  $(1,055,286)  $(434,109)   41%   
    Non-GAAP Measure                       
    AEBITDA  $(177,966)  $(178,630)  $663   0%   

     

    23

     

     

    RELIANCE GLOBAL GROUP, INC. AND SUBSIDIARIES

    CONSOLIDATED STATEMENTS OF OPERATIONS ANALYTICS

     

    Comparison of the six months ended June 30, 2024 to the six months ended June 30, 2023

     

       June 30, 2024   June 30, 2023   Value Fluctuation   Percent Fluctuation   Explanations
    Commission income  $7,315,780   $7,135,008   $180,772    3%  Increased commission income primarily driven by sustained organic growth.
                            
    Commission expense (“CE”)   2,162,905    1,912,600    250,305    13%  Increased CE correlated to growth in revenues.
    Salaries and wages (“S&W”)   3,786,814    3,526,957    259,857    7%  Increased S&W primarily impacted by equity-based pay.
    General and administrative expenses (“G&A”)   2,366,523    1,962,978    403,545    21%  Increased G&A driven by higher acquisition & legal costs related to M&A activity and regulatory filings.
    Marketing and advertising (“M&A”)   204,025    246,432    (42,407)   -17%  M&A decrease consistent with Company’s current marketing strategy
    Change in estimated acquisition earn-out payables   47,761    1,019,925    (972,164)   -95%  Decrease pursuant to the settlement of the majority of earn-out payables.
    Depreciation and amortization (“D&A”)   1,003,941    1,309,227    (305,286)   -23%  Decrease due to impaired intangible assets no longer incurring D&A.
    Asset impairment   3,922,110    -    3,922,110        Increase due to impairment of certain intangible assets.
                            
    Total operating expenses   13,494,079    9,978,119    3,515,960    35%   
                  -         
    Loss from operations   (6,178,299)   (2,843,111)   (3,335,188)   117%   
                  -         
    Other income (expense)             -         
    Interest expense   (735,646)   (722,462)   (13,184)   2%  Increase was primarily due to elevated interest rates.
    Interest related parties   (78,134)   (92,629)   14,495    -16%  Decrease was due to periodic paydowns on loan balances.
    Other income (expense), net   22    (13,297)   13,319    -100%  Decrease due to certain minor non-recurring and non-significant other income/expense sources.
    Recognition and change in fair value of warrant liabilities   156,000    2,673,723    (2,517,723)   -94%  Fluctuation per fair value changes in derivative warrant liabilities.
    Total other (expense) income   (657,758)   1,845,335    (2,503,093)   -136%   
                            
    Loss from continuing operations before tax   (6,836,057)   (997,776)   (5,838,281)   585%   
    Loss from discontinued operations before tax   -    (1,846,048)   1,846,048    -100%  Discontinued operations did not re-occur during 2024.
    Net income (loss)  $(6,836,057)  $(2,843,824)  $(3,992,233)   140%   
    Non-GAAP Measure                       
    AEBITDA  $(251,620)  $(9,288)  $(242,332)   2609%   

     

    24

     

     

    Non-GAAP Reconciliation from Net (Loss) Income to AEBITDA

     

    The following table provides a reconciliation from net loss to AEBITDA for the three and six months ended June 30, 2024 and June 30, 2023.

     

       Three Months Ended June 30,   Six Months Ended June 30, 
       2024   2023   2024   2023 
                     
    Net loss  $(1,489,395)  $(1,055,286)  $(6,836,057)  $(2,843,824)
    Adjustments:                    
    Interest and related party interest expense   403,495    422,058    813,780    815,091 
    Depreciation and amortization   469,788    655,449    1,003,941    1,309,227 
    Asset impairment   -    -    3,922,110    - 
    Share-based compensation to employees, directors and service providers   333,897    413,362    488,808    457,158 
    Change in estimated acquisition earn-out payables   -    543,233    47,761    1,019,925 
    Other (income) expense, net   (11)   16,979    (22)   13,297 
    Transactional costs   119,203    -    373,096    - 
    Nonrecurring costs   45,724    47,513    90,963    47,513 
    Recognition and change in fair value of warrant liabilities   (60,667)   1,592,509    (156,000)   (2,673,723)
    (Income) loss from discontinued operations before tax   

    -

        (2,814,445)   -    1,846,048 
    Total adjustments   1,311,429    876,657    6,584,437    2,834,536 
                         
    AEBITDA  $(177,966)  $(178,630)  $(251,620)  $(9,288)

     

    Liquidity and capital resources

     

    As of June 30, 2024, we had a cash balance of approximately $2,816,000 and working capital of approximately $600,000, compared with a cash balance of approximately $2,739,000 and working capital of approximately $1,189,000 at December 31, 2023. During the first quarter of 2024, the Company entered into an At Market Issuance Sales Agreement with EF Hutton LLC as sales agent (the “ATM Agreement”), pursuant to which the Company may offer and sell, from time to time through the sales agent, shares of its common stock having an aggregate offering price as determined by the then in effect prospectus supplement to the base prospectus included in the registration statement (the “ATM Capacity”).

     

    During the six months ended June 30, 2024, the Company sold 313,713 shares of common stock under the ATM Agreement, at an average price of $5.3492, resulting in proceeds, net of $141,631 in agent commissions and legal and other fees, of $2,068,344. From the net sales proceeds, $146,174 was received in July 2024 and was recorded in the other receivables account in the unaudited condensed consolidated balance sheets as of June 30, 2024. As of the date of filing of this Quarterly Report on Form 10-Q, the net remaining ATM Capacity was $1,728,825.

     

    Inflation

     

    The Company generally may be impacted by rising costs for certain inflation-sensitive operating expenses such as labor, employee benefits, and facility leases. The Company believes inflation could have a material impact on pricing and operating expenses in future periods due to the state of the economy and current inflation rates.

     

    25

     

     

    Off-balance sheet arrangements

     

    We did not have any off-balance sheet arrangements, as such term is defined in Regulation S-K, during the six months ended June 30, 2024.

     

    Cash Flows

     

      

    Six Months Ended

    June 30,

     
       2024   2023 
    Net cash used in operating activities  $(889,594)   (2,007,101)
    Net cash (used in) provided by investing activities   (36,531)   735,128 
    Net cash provided by financing activities   1,002,825    2,042,460 
    Net increase in cash, cash equivalents, and restricted cash  $

    76,700

       $770,487 

     

    Operating Activities

     

    Net cash used in operating activities for the six months ended June 30, 2024, was approximately $890,000, compared to net cash flows used in operating activities of approximately $2.0 million for the six months ended June 30, 2023. The cash used includes a net loss of approximately $6,836,000, decreased by approximate non-cash adjustments of $5,332,000 related to asset impairments of approximately $3,922,000, gain from recognition and change in fair value of warrant liabilities of approximately $156,000, depreciation and amortization of approximately $1,004,000, other adjustments totaling approximately $562,000, as well as a net increase in cash due to changes of net working capital items of approximately $615,000.

     

    Investing Activities

     

    During the six months ended June 30, 2024, cash flows used in investing activities approximated $36,500 compared to cash flows used in investing activities of approximately $735,000 for the six months ended June 30, 2023. The cash used is primarily related to the purchase of fixed tangible and intangible assets.

     

    Financing Activities

     

    During the six months ended June 30, 2024, approximate cash used in financing activities was $1.0 million, as compared to approximately $2.0 million provided for the six months ended June 30, 2023. Net cash used in financing activities relates to proceeds from common shares issued pursuant to the ATM Agreement totaling approximately $2,068,000, offset by net debt principal, net short-term financings, and related party payables repayments of approximately $1,066,000.

     

    Significant Accounting Policies and Estimates

     

    We describe our significant accounting policies in Note 2, Summary of Significant Accounting Policies, of the Notes to Consolidated Financial Statements, and our critical accounting estimates in Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. There have been no significant changes in our significant accounting policies or critical accounting estimates since the end of fiscal year 2023.

     

    Item 3. Quantitative and Qualitative Disclosures About Market Risk.

     

    Not applicable.

     

    Item 4. Controls and Procedures

     

    Evaluation of Disclosure Controls and Procedures

     

    The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), refers to controls and procedures that are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that such information is accumulated and communicated to a company’s management, including its principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosure. Management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving their objectives and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures.

     

    Our Chief Executive Officer and Chief Financial Officer have evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2024, and determined them to be effective as of June 30, 2024.

     

    26

     

     

    Changes in Internal Control over Financial Reporting

     

    During fiscal year 2024, the Company revised its internal controls over its goodwill evaluation process to ensure that any testing performed at interim dates are rolled forward to the reporting date of the relevant financial statements. Aside from the foregoing, there have been no changes in our internal control over financial reporting, as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act, during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

     

    PART II

     

    Item 1. Legal Proceedings.

     

    We are subject to various legal proceedings and claims, either asserted or unasserted, arising in the ordinary course of business. While the outcome of these claims cannot be predicted with certainty, management does not believe the outcome of any of these matters will have a material adverse effect on our business, financial position, results of operations, or cash flows, and accordingly, no legal contingencies are accrued as of June 30, 2024. Litigation relating to the insurance brokerage industry is not uncommon. As such we, from time to time have been, subject to such litigation. No assurances can be given with respect to the extent or outcome of any such litigation in the future.

     

    Item 1A. Risk Factors.

     

    Investing in our common stock involves a high degree of risk. You should consider carefully the information disclosed in Part I, Item 1A, “Risk Factors,” contained in our Annual Report on Form 10-K for the year ended December 31, 2023. Except as disclosed below, there have been no material changes from the risk factors disclosed in our Annual Report on Form 10-K for the year ended December 31, 2023, as amended from time to time.

     

    Our shares of common stock are currently listed on Nasdaq. If we fail to satisfy the continued listing requirements of The Nasdaq Capital Market, such as the corporate governance requirements, minimum bid price requirement or the minimum stockholders’ equity requirement, Nasdaq may take steps to delist our common stock. Any delisting would likely have a negative effect on the price of our common stock and would impair stockholders’ ability to sell or purchase their common stock when they wish to do so.

     

    As previously disclosed in the Current Report on Form 8-K filed on January 16, 2024 by the Company on January 12, 2024, the Company received written notice from Nasdaq’s Listing Qualifications Department notifying the Company that for the preceding 30 consecutive business days (November 29, 2023 to January 11, 2024), the Company’s common stock did not maintain a minimum closing bid price of $1.00 per share as required by Nasdaq Listing Rule 5550(a)(2). The notice has no immediate effect on the listing or trading of the Company’s common stock and the common stock continued to trade on Nasdaq under the symbol “RELI.” In accordance with Nasdaq Listing Rule 5810(c)(3)(A), the Company has a compliance period of 180 calendar days, or until July 10, 2024, to regain compliance with Nasdaq Listing Rule 5550(a) (2).

     

    On July 16, 2024 Nasdaq’s Listing Qualifications Department notified the Company that it had regained compliance with Nasdaq Listing Rule 5550(a)(2).

     

    Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

     

    The following table displays the unregistered sales of equity securities and use of proceeds.

     

    Date of

    Transaction

     

    Transaction type

    (e.g. new issuance,

    cancellation,

    shares returned to

    treasury) and all

    under Section

    4(a)(2) of the

    Securities
    Act of 1933

     

    Number of

    Securities

    Issued (or

    cancelled) (1)

       Class of Securities  Value of Securities issued ($/per share) at Issuance   Were the Securities issued at a discount to market price at the time of issuance? (Yes/No) 

    Individual/

    Entity Securities

    were issued to

    (entities must have

    individual

    with voting /

    investment

    control

    disclosed).

     

    Reason for

    Securities

    issuance (e.g. for

    cash or debt

    conversion) OR

    Nature of

    Services

    Provided (if

    applicable)

     

    Restricted or

    Unrestricted

    as of this

    filing?

       Exemption or Registration Type? 
    4/25/2024  New   30,029   Common   5.91   No  Julie A. Blockey  Acquisition   

    Restricted

            4(a)(2)
    5/21/2024  New   17,825   Common   5.61   No  Outside The Box Capital Inc.  Services   

    Restricted

        4(a)(2)

     

    (1) Gives effect to a 1:17 reverse stock split effective as of July 1, 2024

     

    27

     

     

    Item 3. Defaults Upon Senior Securities.

     

    Not applicable.

     

    Item 4. Mine Safety Disclosures.

     

    Not applicable.

     

    Item 5. Other Information.

     

    (a) None.

     

    (b) There have been no material changes to the procedures by which security holders may recommend nominees to the Company’s Board of Directors since the Company last provided disclosure in response to the requirements of Item 407(c)(3) of Regulation S-K.

     

    (c) During the quarter ended June 30, 2024, no director or officer adopted or terminated: (i) any contract, instruction or written plan for the purchase or sale of securities of the registrant intended to satisfy the affirmative defense conditions of Rule 10b5-1(c) (a “Rule 10b5-1 trading arrangement”); and/or (ii) any “non-Rule 10b5-1 trading arrangement” as defined in Item 408(c) of Regulation S-K

     

    Item 6. Exhibits

     

    The following exhibits are filed or furnished with this Quarterly Report on Form 10-Q.

     

    Exhibit No.   Description
         
    10.1   Reliance Global Group, Inc. 2024 Equity Incentive Plan (incorporated by reference to Exhibit 99.1 to the registrant’s registration statement on Form S-8 filed with the Securities and Exchange Commission on April 18, 2024).
         
    10.2   Stock Exchange Agreement by and among Reliance Global Group, Inc., Jonathan S. Spetner, Michelle Spetner and Spetner Associates, Inc. dated May 14, 2024 (incorporated by reference to Exhibit 10.1 to the registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on May 15, 2024).
         
    10.3   Certificate of Amendment to the registrant’s Amended and Restated Articles of Incorporation, as amended, dated June 26, 2024 (incorporated by reference to Exhibit 3.1 to the registrant’s Current Report on Form 8-K filed with the Securities and Exchange Commission on June 26, 2024).
         
    31.1*   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
         
    31.2*   Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
         
    32.1**   Section 1350 Certification of the Chief Executive Officer and Chief Financial Officer
         
    101.INS*   Inline XBRL Instance Document
    101.CAL*   Inline XBRL Taxonomy Extension Calculation Linkbase Document
    101.SCH*   Inline XBRL Taxonomy Extension Schema Document
    101.DEF*   Inline XBRL Taxonomy Extension Definition Linkbase Document
    101.LAB*   Inline XBRL Taxonomy Extension Labels Linkbase Document
    101.PRE*   Inline XBRL Taxonomy Extension Presentation Linkbase Document
    104   Cover Page Interactive Data File (formatted in IXBRL, and included in exhibit 101).

     

    *Filed herewith

    **Furnished herewith

     

    28

     

     

    SIGNATURES

     

    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

     

      Reliance Global Group, Inc.
         
    Date: July 25, 2024 By:  /s/ Ezra Beyman
        Ezra Beyman
        Chief Executive Officer
        (principal executive officer)
         
    Date: July 25, 2024 By: /s/ Joel Markovits
        Joel Markovits
        Chief Financial Officer
        (principal financial officer and principal accounting officer)

     

    29

     

    Get the next $RELI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $RELI

    DatePrice TargetRatingAnalyst
    2/2/2022$7.00Buy
    EF Hutton
    More analyst ratings

    $RELI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman and CEO Beyman Ezra was granted 249,000 shares, covered exercise/tax liability with 55,787 shares and bought $8,502 worth of shares (30,000 units at $0.28), increasing direct ownership by 73% to 527,100 units (SEC Form 4)

    4 - Reliance Global Group, Inc. (0001812727) (Issuer)

    6/28/24 6:10:12 AM ET
    $RELI
    Specialty Insurers
    Finance

    Amendment: Chairman and CEO Beyman Ezra disposed of 289,277 shares, acquired $43,003 worth of shares (356,020 units at $0.12), was granted 168,000 shares, covered exercise/tax liability with 88,382 shares, bought $50,220 worth of shares (186,000 units at $0.27) and gifted 96,667 shares, increasing direct ownership by 694% to 303,886 units (SEC Form 4)

    4/A - Reliance Global Group, Inc. (0001812727) (Issuer)

    6/28/24 6:06:37 AM ET
    $RELI
    Specialty Insurers
    Finance

    Beyman Ezra acquired 289,277 shares, was granted 168,000 shares, covered exercise/tax liability with 88,382 shares, bought $50,220 worth of shares (186,000 units at $0.27), gifted 96,667 shares and disposed of 289,277 shares, increasing direct ownership by 694% to 303,886 units (SEC Form 4)

    4 - Reliance Global Group, Inc. (0001812727) (Issuer)

    5/30/24 7:34:57 PM ET
    $RELI
    Specialty Insurers
    Finance

    $RELI
    SEC Filings

    View All

    SEC Form 424B4 filed by Reliance Global Group Inc.

    424B4 - Reliance Global Group, Inc. (0001812727) (Filer)

    1/29/26 10:02:21 AM ET
    $RELI
    Specialty Insurers
    Finance

    SEC Form EFFECT filed by Reliance Global Group Inc.

    EFFECT - Reliance Global Group, Inc. (0001812727) (Filer)

    1/29/26 12:15:25 AM ET
    $RELI
    Specialty Insurers
    Finance

    SEC Form S-1 filed by Reliance Global Group Inc.

    S-1 - Reliance Global Group, Inc. (0001812727) (Filer)

    1/23/26 8:42:08 AM ET
    $RELI
    Specialty Insurers
    Finance

    $RELI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EXEC VP, INSURANCE DIVISION Beyman Yaakov covered exercise/tax liability with 14,170 shares, decreasing direct ownership by 6% to 236,794 units (SEC Form 4)

    4 - Reliance Global Group, Inc. (0001812727) (Issuer)

    9/2/25 4:05:34 PM ET
    $RELI
    Specialty Insurers
    Finance

    Chairman and CEO Beyman Ezra covered exercise/tax liability with 62,845 shares, was granted 717,775 shares and gifted 12,000 shares, increasing direct ownership by 216% to 958,123 units (SEC Form 4)

    4 - Reliance Global Group, Inc. (0001812727) (Issuer)

    9/2/25 4:05:36 PM ET
    $RELI
    Specialty Insurers
    Finance

    Chief Financial Officer Markovits Joel covered exercise/tax liability with 32,483 shares, decreasing direct ownership by 9% to 327,707 units (SEC Form 4)

    4 - Reliance Global Group, Inc. (0001812727) (Issuer)

    9/2/25 4:05:32 PM ET
    $RELI
    Specialty Insurers
    Finance

    $RELI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Reliance Global Group Enters Term Sheet to Acquire Controlling Stake in Enquantum, a Post-Quantum Cybersecurity Company

    LAKEWOOD, NJ, Jan. 26, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:EZRA) (the "Company") today announced that it has entered into a non-binding term sheet to acquire a controlling interest in Enquantum Ltd., a post-quantum cryptography technology company addressing what many experts view as an emerging and systemic threat to essential global services and digital infrastructure that rely on encryption for security. In addition, in connection with the term sheet, On January 15, 2026, Reliance executed a secured promissory note as an advance of the initial funding under a definitive agreement, if executed. The Promissory Note is secured by all of the assets of Enquantum and p

    1/26/26 9:00:00 AM ET
    $RELI
    Specialty Insurers
    Finance

    Reliance Global Group Announces NASDAQ Ticker Symbol Change from "RELI" to "EZRA" Following Recent Announcement of First Planned Acquisition Under EZRA International Group

    Company to Begin Trading Under New Symbol "EZRA" on January 26, 2026 Acquisition Strategy Offers Transformative Potential, Complementing Cash Flow Foundation of Insurance Holdings LAKEWOOD, NJ, Jan. 22, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:RELI) (the "Company") today announced that its ticker symbol on the NASDAQ Capital Market will change from "RELI" to "EZRA", effective at the open of trading on Monday, January 26, 2026. The Company's common stock will continue to be listed on NASDAQ, and its CUSIP number will remain unchanged. The ticker symbol change is intended to better reflect the Company's strategic evolution, including the formation of EZRA International

    1/22/26 9:45:00 AM ET
    $RELI
    Specialty Insurers
    Finance

    Reliance Global Group Signs Term Sheet to Acquire Majority Stake in Israeli AI Diagnostic Company, Scentech, Positioning for Entry into the Multi-Billion Dollar Early Disease Detection Market

    Transaction structured to achieve majority ownership through performance-based clinical and regulatory milestones Marks first strategic acquisition for new division—Ezra International Group Lakewood, NJ, Jan. 07, 2026 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:RELI) ("Reliance" or the "Company") today announced that it has entered into a non-binding term sheet ("the term sheet") to acquire a majority equity position of Scent Medical Technologies Ltd ("Scentech"). Scentech is a diagnostics company developing artificial intelligence technologies designed to identify disease-associated molecular signatures in human breath. Scentech's product candidates are under development and

    1/7/26 8:30:00 AM ET
    $RELI
    Specialty Insurers
    Finance

    $RELI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    EF Hutton initiated coverage on Reliance Global Group with a new price target

    EF Hutton initiated coverage of Reliance Global Group with a rating of Buy and set a new price target of $7.00

    2/2/22 9:08:11 AM ET
    $RELI
    Specialty Insurers
    Finance

    $RELI
    Leadership Updates

    Live Leadership Updates

    View All

    Reliance Global Group Announces Formation of New Real Estate Division Aimed at Expanding Operations

    LAKEWOOD, N.J., July 01, 2024 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:RELI, RELIW))) ("Reliance", "we" or the "Company") today announced the formation of a new Real Estate division drawing on Ezra Beyman's extensive background in building the third-largest mortgage brokerage in the nation and accumulating a multi-billion-dollar portfolio of multi-family properties. Furthermore, Abe Miller, successful real estate investor and M&A executive, has agreed to join Reliance to oversee this new division and advise on future real estate transactions. Mr. Miller will receive no fixed salary for his services; rather, he will be compensated entirely on a success-based model. The new di

    7/1/24 8:30:00 AM ET
    $RELI
    Specialty Insurers
    Finance

    Reliance Global Group Appoints Senior Corporate Finance Executive William Lebovics as Chief Financial Office

    LAKEWOOD, NJ, May 31, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Reliance Global Group, Inc. (NASDAQ:RELI, RELIW))) ("Reliance", "we" or the "Company"), which combines artificial intelligence (AI) and cloud-based technologies with the personalized experience of a traditional insurance agency, today announces the appointment of Mr. William Lebovics as Chief Financial Officer, effective June 1, 2022.  Mr. Blumenfrucht, who previously served as Chief Financial Officer, will continue as a member of the Company's Board of Directors and will provide support through the transition period. Among his accomplishments, Mr. Lebovics served as the Finance Manager for IDW Media Holdings, where he w

    5/31/22 8:00:00 AM ET
    $RELI
    Specialty Insurers
    Finance

    Reliance Global Group Achieves 82% Increase in Revenue for the First Quarter of 2022

    Continues Successful Execution of Growth Strategy through Key Acquisitions and Senior Management Appointments LAKEWOOD, NJ, May 16, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Reliance Global Group, Inc. (NASDAQ:RELI, RELIW))) ("Reliance", "we" or the "Company"), which combines artificial intelligence (AI) and cloud-based technologies with the personalized experience of a traditional insurance agency, provided a business update today and reported financial results for the first quarter ended March 31, 2022.  Ezra Beyman, CEO of Reliance Global Group, commented, "We continue to execute on our business growth strategy, as evidenced by an 82% increase in revenue to $4.2 million for the firs

    5/16/22 8:00:00 AM ET
    $RELI
    Specialty Insurers
    Finance

    $RELI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Reliance Global Group Inc.

    SC 13G/A - Reliance Global Group, Inc. (0001812727) (Subject)

    11/14/24 4:26:59 PM ET
    $RELI
    Specialty Insurers
    Finance

    SEC Form SC 13G filed by Reliance Global Group Inc.

    SC 13G - Reliance Global Group, Inc. (0001812727) (Subject)

    2/14/24 3:51:40 PM ET
    $RELI
    Specialty Insurers
    Finance

    SEC Form SC 13G/A filed by Reliance Global Group Inc. (Amendment)

    SC 13G/A - Reliance Global Group, Inc. (0001812727) (Subject)

    2/6/24 1:33:58 PM ET
    $RELI
    Specialty Insurers
    Finance

    $RELI
    Financials

    Live finance-specific insights

    View All

    Reliance Global Group (RELI) Adds to Zcash (ZEC) Position, and Continues Implementing Its Institutional ZEC Adoption Strategy

    LAKEWOOD, NJ, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:RELI) ("Reliance", "we" or the "Company") today announced that it has deployed additional cash to increase its Zcash (ZEC) position. This additional allocation to the Company's Digital Asset Treasury ("DAT") reflects the Company's internal view that ZEC may be an institutionally adaptable and technologically resilient privacy-enabled digital asset and may play a meaningful role in its long-term treasury strategy. Zcash's dual architecture which combines transparent auditability with optional privacy in the Company's view supports its appeal to organizations seeking digital assets that can be implemented fo

    12/8/25 2:40:00 PM ET
    $RELI
    Specialty Insurers
    Finance

    Reliance Global Group Increases Zcash (ZEC) Position Through Additional Cash Deployment

    LAKEWOOD, NJ, Nov. 26, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:RELI) ("Reliance", "we" or the "Company") today announced that it has deployed additional cash into its Zcash (ZEC) position, as part of its focused Digital Asset Treasury ("DAT") strategy. This step follows Reliance's recent consolidation of its digital asset holdings into Zcash and reflects the Company's current view of ZEC as its primary digital asset exposure within that strategy. Zcash's architecture, featuring a Bitcoin-based security model enhanced with optional privacy and selective disclosure, continues to distinguish it from other blockchain networks. Its dual-transaction model provides transpare

    11/26/25 9:30:00 AM ET
    $RELI
    Specialty Insurers
    Finance

    Reliance Global Group (RELI) Consolidates Digital Asset Treasury Into Zcash (ZEC)

    LAKEWOOD, NJ, Nov. 25, 2025 (GLOBE NEWSWIRE) -- Reliance Global Group, Inc. (NASDAQ:RELI) ("Reliance", "we" or the "Company") today announced that it has completed a strategic realignment of its Digital Asset Treasury ("DAT"), by consolidating its digital asset position into Zcash (ZEC). The Company has fully exited its prior holdings and reallocated the proceeds into Zcash, a leading privacy-preserving cryptocurrency built on Bitcoin's foundational architecture. This decision follows a comprehensive strategic review in which the Company along with Blake Janover, the Chaiman of the Crypto Advisory Board determined, after an in-depth assessment, that Zcash presented the most compelling opp

    11/25/25 8:30:00 AM ET
    $RELI
    Specialty Insurers
    Finance